The University of Chicago Header Logo

Michael Charlton

TitleProfessor
InstitutionUniversity of Chicago
DepartmentMedicine-Gastroenterology
AddressChicago IL 60637
vCardDownload vCard

    Collapse Research 
    Collapse research activities and funding
    R01DK069757     (CHARLTON, MICHAEL R)Apr 1, 2005 - Mar 31, 2010
    NIH
    Pathophysiology and Characterisation of NAFLD
    Role: Principal Investigator

    R03DK054627     (CHARLTON, MICHAEL R)Sep 30, 1998 - Sep 29, 2000
    NIH
    REDUCTION OF HCV RECURRANCE AFTER LIVER TRANSPLANTATION
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Parthasarathy G, Mauer AS, Golla N, Daniel PV, Kim LH, Sidhu GS, Marek Rd GW, Loeuillard E, Krishnan A, Kim Lee HS, Pavelko KD, Charlton M, Hirsova P, Ilyas SI, Malhi H, Parthasarathy G, Mauer AS, Golla N, Daniel PV, Kim LH, Sidhu GS, Marek GW, Loeuillard E, Krishnan A, Lee HSK, Pavelko KD, Charlton M, Hirsova P, Ilyas SI, Malhi H. Macrophage RAGE activation is proinflammatory in NASH. JCI Insight. 2024 Feb 08; 9(3). PMID: 38175729.
      Citations:    Fields:    
    2. Harrison SA, Bedossa P, Guy CD, Schattenberg JM, Loomba R, Taub R, Labriola D, Moussa SE, Neff GW, Rinella ME, Anstee QM, Abdelmalek MF, Younossi Z, Baum SJ, Francque S, Charlton MR, Newsome PN, Lanthier N, Schiefke I, Mangia A, Pericàs JM, Patil R, Sanyal AJ, Noureddin M, Bansal MB, Alkhouri N, Castera L, Rudraraju M, Ratziu V, MAESTRO-NASH Investigators. A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis. N Engl J Med. 2024 Feb 08; 390(6):497-509. PMID: 38324483.
      Citations:    Fields:    
    3. Odenwald MA, Lin H, Lehmann C, Dylla NP, Cole CG, Mostad JD, Pappas TE, Ramaswamy R, Moran A, Hutchison AL, Stutz MR, Dela Cruz M, Adler E, Boissiere J, Khalid M, Cantoral J, Haro F, Oliveira RA, Waligurski E, Cotter TG, Light SH, Beavis KG, Sundararajan A, Sidebottom AM, Reddy KG, Paul S, Pillai A, Te HS, Rinella ME, Charlton MR, Pamer EG, Aronsohn AI. Bifidobacteria metabolize lactulose to optimize gut metabolites and prevent systemic infection in patients with liver disease. Nat Microbiol. 2023 Nov; 8(11):2033-2049. PMID: 37845315.
      Citations: 1     Fields:    Translation:HumansAnimals
    4. Flamm S, Lawitz E, Borg B, Charlton M, Landis C, Reddy KR, Shiffman M, Alsina A, Chang C, Ravendhran N, Hernandez C, Hézode C, Scherbakovsky S, Mercier RC, Samuel D. Efficacy and Safety of Sofosbuvir/Velpatasvir Plus Ribavirin in Patients with Hepatitis C Virus-Related Decompensated Cirrhosis. Viruses. 2023 09 29; 15(10). PMID: 37896803; PMCID: PMC10611233.
      Citations: 1     Fields:    Translation:HumansCells
    5. Hutchison AL, Tavaglione F, Romeo S, Charlton M. Endocrine aspects of metabolic dysfunction-associated steatotic liver disease (MASLD): Beyond insulin resistance. J Hepatol. 2023 12; 79(6):1524-1541. PMID: 37730124.
      Citations: 2     Fields:    Translation:HumansCells
    6. Shelley K, Articolo A, Luthra R, Charlton M. Clinical characteristics and management of patients with nonalcoholic steatohepatitis in a real-world setting: analysis of the Ipsos NASH therapy monitor database. BMC Gastroenterol. 2023 May 19; 23(1):160. PMID: 37208593; PMCID: PMC10197394.
      Citations:    Fields:    Translation:Humans
    7. Gadano AC, Martic M, Kochuparampil J, Naoumov NV, Anstee QM, Lucas KJ, Francque S, Abdelmalek MF, Sanyal AJ, Ratziu V, Rinella M, Charlton M, Loomba R, Mena E, Schattenberg JM, Noureddin M, Lazas D, Goh GBB, Sarin SK, Yilmaz Y, Stringer R, Chen L, Rodriguez-Araujo G, Chng E, Brass C, Pedrosa MC. Tropifexor plus cenicriviroc combination versus monotherapy in nonalcoholic steatohepatitis: Results from the phase 2b TANDEM study. Hepatology. 2023 10 01; 78(4):1223-1239. PMID: 37162151; PMCID: PMC10521801.
      Citations: 4     Fields:    Translation:Humans
    8. Davies ER, Ryan KA, Bewley KR, Coombes NS, Salguero FJ, Carnell OT, Biddlecombe S, Charlton M, Challis A, Cross ES, Handley A, Ngabo D, Weldon TM, Hall Y, Funnell SGP. The Omicron Sub-Variant BA.4 Displays a Remarkable Lack of Clinical Signs in a Golden Syrian Hamster Model of SARS-CoV-2 Infection. Viruses. 2023 05 10; 15(5). PMID: 37243219; PMCID: PMC10224153.
      Citations:    Fields:    Translation:AnimalsCells
    9. Terrault NA, Francoz C, Berenguer M, Charlton M, Heimbach J. Liver Transplantation 2023: Status Report, Current and Future Challenges. Clin Gastroenterol Hepatol. 2023 07; 21(8):2150-2166. PMID: 37084928.
      Citations: 7     Fields:    Translation:Humans
    10. Handley A, Ryan KA, Davies ER, Bewley KR, Carnell OT, Challis A, Coombes NS, Fotheringham SA, Gooch KE, Charlton M, Harris DJ, Kennard C, Ngabo D, Weldon TM, Salguero FJ, Funnell SGP, Hall Y. SARS-CoV-2 Disease Severity in the Golden Syrian Hamster Model of Infection Is Related to the Volume of Intranasal Inoculum. Viruses. 2023 03 14; 15(3). PMID: 36992457; PMCID: PMC10051760.
      Citations: 3     Fields:    Translation:HumansAnimalsCells
    11. Fei N, Miyoshi S, Hermanson JB, Miyoshi J, Xie B, DeLeon O, Hawkins M, Charlton W, D'Souza M, Hart J, Sulakhe D, Martinez-Guryn KB, Chang EB, Charlton MR, Leone VA. Imbalanced gut microbiota predicts and drives the progression of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis in a fast-food diet mouse model. bioRxiv. 2023 Jan 09. PMID: 36712061; PMCID: PMC9882021.
      Citations:    
    12. Charlton M, Ratziu V. Rational combination therapy for NASH: Insights from clinical trials and error. J Hepatol. 2023 05; 78(5):1073-1079. PMID: 36603662.
      Citations: 4     Fields:    Translation:Humans
    13. Jamil OK, Faust N, Cotter TG, Paul S, di Sabato D, Fung J, Charlton M, Sandikçi B. Relatively Poor Long-term Outcomes Following Liver Transplantation for NASH in the United States. Transplantation. 2022 10 01; 106(10):2006-2018. PMID: 35765128.
      Citations: 3     Fields:    Translation:Humans
    14. Cotter TG, Odenwald MA, Perez-Gutierrez A, Jayant K, DiSabato D, Charlton M, Fung J. Preservation solutions for static cold storage in donation after circulatory death and donation after brain death liver transplantation in the United States. Liver Transpl. 2022 09; 28(9):1454-1462. PMID: 35313073; PMCID: PMC9544683.
      Citations: 1     Fields:    Translation:Humans
    15. Amin NB, Darekar A, Anstee QM, Wong VW, Vourvahis M, Lee DS, Charlton M, Alkhouri N, Nakajima A, Yunis C, Tacke F. Efficacy and safety of an orally administered DGAT2 inhibitor alone or coadministered with a liver-targeted ACC inhibitor in adults with non-alcoholic steatohepatitis (NASH): rationale and design of the phase II, dose-ranging, dose-finding, randomised, placebo-controlled MIRNA (Metabolic Interventions to Resolve NASH with fibrosis) study. BMJ Open. 2022 03 30; 12(3):e056159. PMID: 35354614; PMCID: PMC8968568.
      Citations: 6     Fields:    Translation:HumansCTClinical Trials
    16. Cotter TG, Odenwald MA, Lieber SR, Rich NE, Im G, Charlton M, Singal AG, Mitchell MC. The Practice of Retransplantation for Recurrent Alcohol-associated Liver Disease in the United States Is Uncommon With Acceptable Outcomes. Transplant Direct. 2022 Mar; 8(3):e1297. PMID: 35187219; PMCID: PMC8843372.
      Citations:    
    17. Cotter TG, Charlton M. The Authors' Reply: Geographic Variation in the Utilization of HCV-viremic Donors Into HCV-negative Recipients. Transplantation. 2022 02 01; 106(2):e166. PMID: 35100228.
      Citations:    Fields:    Translation:Humans
    18. Brunt EM, Clouston AD, Goodman Z, Guy C, Kleiner DE, Lackner C, Tiniakos DG, Wee A, Yeh M, Leow WQ, Chng E, Ren Y, Boon Bee GG, Powell EE, Rinella M, Sanyal AJ, Neuschwander-Tetri B, Younossi Z, Charlton M, Harrison SA, Tai D, Anstee QM, Ratziu V. Complexity of ballooned hepatocyte feature recognition: Defining a training atlas for artificial intelligence-based imaging in NAFLD. J Hepatol. 2022 05; 76(5):1030-1041. PMID: 35090960; PMCID: PMC10544770.
      Citations: 27     Fields:    Translation:HumansCells
    19. Mikolajczyk AE, Zilberstein N, McConville JF, Pan A, Aronsohn AI, Te HS, Reddy G, Paul S, Pillai A, Charlton M, Farnan JM. Mandatory Hepatology Education for Internal Medicine Residents: Long-Term Effects and Implications for Workforce Needs. Hepatol Commun. 2021 11; 5(11):1953-1963. PMID: 34558840; PMCID: PMC8557317.
      Citations: 1     Fields:    Translation:Humans
    20. Wang Y, Crittenden DB, Eng C, Zhang Q, Guo P, Chung D, Fenaux M, Klucher K, Jones C, Jin F, Quirk E, Charlton MR. Safety, Pharmacokinetics, Pharmacodynamics, and Formulation of Liver-Distributed Farnesoid X-Receptor Agonist TERN-101 in Healthy Volunteers. Clin Pharmacol Drug Dev. 2021 10; 10(10):1198-1208. PMID: 34302449.
      Citations: 6     Fields:    Translation:HumansCTClinical Trials
    21. Cotter TG, Minhem M, Wang J, Peeraphatdit T, Ayoub F, Pillai A, Hernandez-Alejandro R, di Sabato D, Charlton M. Living Donor Liver Transplantation in the United States: Evolution of Frequency, Outcomes, Center Volumes, and Factors Associated With Outcomes. Liver Transpl. 2021 07; 27(7):1019-1031. PMID: 33619854; PMCID: PMC9257956.
      Citations: 11     Fields:    Translation:Humans
    22. Kawaguchi T, Charlton M, Kawaguchi A, Yamamura S, Nakano D, Tsutsumi T, Zafer M, Torimura T. Effects of Mediterranean Diet in Patients with Nonalcoholic Fatty Liver Disease: A Systematic Review, Meta-Analysis, and Meta-Regression Analysis of Randomized Controlled Trials. Semin Liver Dis. 2021 08; 41(3):225-234. PMID: 34147036.
      Citations: 17     Fields:    Translation:Humans
    23. Cotter TG, Wang J, Lieber SR, Odenwald MA, Rich NE, Marrero JA, Singal AG, Mitchell MC, Aronsohn A, Charlton M, Fung J. "Raising HOPE": Improved Outcomes for HIV/HCV-coinfected Liver Transplant Recipients in the Direct-acting Antiviral Era. Transplant Direct. 2021 Jul; 7(7):e707. PMID: 34124343; PMCID: PMC8191686.
      Citations: 5     
    24. Cotter TG, Aronsohn A, Reddy KG, Charlton M. Liver Transplantation of HCV-viremic Donors Into HCV-negative Recipients in the United States: Increasing Frequency With Profound Geographic Variation. Transplantation. 2021 06 01; 105(6):1285-1290. PMID: 32639400; PMCID: PMC9206877.
      Citations: 5     Fields:    Translation:Humans
    25. Cotter TG, Wang J, Peeraphatdit T, Ayoub F, Kim G, Te H, Jeevanandam V, Sabato D, Charlton M, Sandikçi B. Simultaneous Heart-Liver Transplantation for Congenital Heart Disease in the United States: Rapidly Increasing With Acceptable Outcomes. Hepatology. 2021 04; 73(4):1464-1477. PMID: 32559317.
      Citations: 5     Fields:    Translation:Humans
    26. Witkowski P, Philipson LH, Kaufman DB, Ratner LE, Abouljoud MS, Bellin MD, Buse JB, Kandeel F, Stock PG, Mulligan DC, Markmann JF, Kozlowski T, Andreoni KA, Alejandro R, Baidal DA, Hardy MA, Wickrema A, Mirmira RG, Fung J, Becker YT, Josephson MA, Bachul PJ, Pyda JS, Charlton M, Millis JM, Gaglia JL, Stratta RJ, Fridell JA, Niederhaus SV, Forbes RC, Jayant K, Robertson RP, Odorico JS, Levy MF, Harland RC, Abrams PL, Olaitan OK, Kandaswamy R, Wellen JR, Japour AJ, Desai CS, Naziruddin B, Balamurugan AN, Barth RN, Ricordi C, “Islets for US” Collaborative. The demise of islet allotransplantation in the United States: A call for an urgent regulatory update. Am J Transplant. 2021 04; 21(4):1365-1375. PMID: 33251712; PMCID: PMC8016716.
      Citations: 8     Fields:    Translation:Humans
    27. Generette GS, Bachul PJ, Golab K, Basto L, Pyda JS, Borek P, Tibudan M, Anteby R, Perea L, Charlton M, Perez-Gutierrez A, Jayant K, Lucander A, Matthews JB, Millis JM, Fung J, Witkowski P. En bloc liver and pancreas transplantation after total pancreatectomy with autologous islet transplantation. Eur J Transl Clin Med. 2020; 3(2):11-17. PMID: 33409500; PMCID: PMC7785098.
      Citations:    
    28. Cotter TG, Ayoub F, King AC, Reddy KG, Charlton M. Practice Habits, Knowledge, and Attitudes of Hepatologists to Alcohol Use Disorder Medication: Sobering Gaps and Opportunities. Transplant Direct. 2020 Oct; 6(10):e603. PMID: 33134483; PMCID: PMC7591123.
      Citations: 4     
    29. Cotter TG, Paul S, Gampa A, Wang J, Te H, Pillai A, Reddy KG, di Sabato D, Little EC, Sundaram V, Fung J, Lucey MR, Charlton M, Sandikçi B. Liver transplantation for alcoholic hepatitis in the United States: Excellent outcomes with profound temporal and geographic variation in frequency. Am J Transplant. 2021 03; 21(3):1039-1055. PMID: 32531107.
      Citations: 15     Fields:    Translation:Humans
    30. Albhaisi S, Kim K, Baker J, Chidambaram N, Patel MV, Charlton M, Sanyal AJ. LPCN 1144 Resolves NAFLD in Hypogonadal Males. Hepatol Commun. 2020 Oct; 4(10):1430-1440. PMID: 33024914; PMCID: PMC7527694.
      Citations: 6     Fields:    
    31. Kim TH, Banini BA, Asumda FZ, Campbell NA, Hu C, Moser CD, Shire AM, Han S, Ma C, Krishnan A, Mounajjed T, White TA, Gores GJ, LeBrasseur NK, Charlton MR, Roberts LR. Knockout of sulfatase 2 is associated with decreased steatohepatitis and fibrosis in a mouse model of nonalcoholic fatty liver disease. Am J Physiol Gastrointest Liver Physiol. 2020 09 01; 319(3):G333-G344. PMID: 32683952; PMCID: PMC7509257.
      Citations: 2     Fields:    Translation:AnimalsCells
    32. Charlton MR, Alam A, Shukla A, Dashtseren B, Lesmana CRA, Duger D, Payawal DA, Duy Cuong D, Jargalsaikhan G, Cua IHY, Sollano JD, Singh KR, Madan K, Win KM, Kyi KP, Tun KS, Salih M, Rastogi M, Saraf N, Thuy PTT, Hien PTD, Gani RA, Mohamed R, Tanwandee T, Piratvisuth T, Sukeepaisarnjaroen W, Naing W, Hashmi ZY. An expert review on the use of tenofovir alafenamide for the treatment of chronic hepatitis B virus infection in Asia. J Gastroenterol. 2020 Sep; 55(9):811-823. PMID: 32666200; PMCID: PMC7452871.
      Citations: 18     Fields:    Translation:Humans
    33. Peeraphatdit TB, Wang J, Odenwald MA, Hu S, Hart J, Charlton MR. Hepatotoxicity From Immune Checkpoint Inhibitors: A Systematic Review and Management Recommendation. Hepatology. 2020 07; 72(1):315-329. PMID: 32167613.
      Citations: 69     Fields:    Translation:Humans
    34. Micic D, Oto A, Charlton MR, Benoit JL, Siegler M. Hiding in the Water. N Engl J Med. 2020 May 07; 382(19):1844-1849. PMID: 32374966.
      Citations: 6     Fields:    Translation:HumansAnimals
    35. Charlton M. The Future of Treatment for Nonalcoholic Steatohepatitis. Gastroenterol Hepatol (N Y). 2020 May; 16(5):258-261. PMID: 34035728; PMCID: PMC8132637.
      Citations:    
    36. Cotter TG, Dong L, Holmen J, Gilroy R, Krong J, Charlton M. Nonalcoholic fatty liver disease: impact on healthcare resource utilization, liver transplantation and mortality in a large, integrated healthcare system. J Gastroenterol. 2020 Jul; 55(7):722-730. PMID: 32328797.
      Citations: 7     Fields:    Translation:Humans
    37. Gane EJ, Charlton MR, Mohamed R, Sollano JD, Tun KS, Pham TTT, Payawal DA, Gani RA, Muljono DH, Acharya SK, Zhuang H, Shukla A, Madan K, Saraf N, Tyagi S, Singh KR, Cua IHY, Jargalsaikhan G, Duger D, Sukeepaisarnjaroen W, Purnomo HD, Hasan I, Lesmana LA, Lesmana CRA, Kyi KP, Naing W, Ravishankar AC, Hadigal S. Asian consensus recommendations on optimizing the diagnosis and initiation of treatment of hepatitis B virus infection in resource-limited settings. J Viral Hepat. 2020 05; 27(5):466-475. PMID: 31785182.
      Citations: 3     Fields:    Translation:HumansCells
    38. Cotter TG, Charlton M. Nonalcoholic Steatohepatitis After Liver Transplantation. Liver Transpl. 2020 01; 26(1):141-159. PMID: 31610081.
      Citations: 25     Fields:    Translation:Humans
    39. Pedrosa M, Seyedkazemi S, Francque S, Sanyal A, Rinella M, Charlton M, Loomba R, Kochuparampil J, Fischer L, Vaidyanathan S, Anstee QM, Ratziu V. A randomized, double-blind, multicenter, phase 2b study to evaluate the safety and efficacy of a combination of tropifexor and cenicriviroc in patients with nonalcoholic steatohepatitis and liver fibrosis: Study design of the TANDEM trial. Contemp Clin Trials. 2020 01; 88:105889. PMID: 31731005.
      Citations: 44     Fields:    Translation:HumansCTClinical Trials
    40. Ebong IA, Sayer G, Kim G, Jeevanandam V, Baker T, Becker Y, Fung J, Charlton M, Te H, Josephson M, Uriel N. Simultaneous heart, liver and kidney transplantation: A viable option for heart failure patients with multiorgan failure. J Heart Lung Transplant. 2019 09; 38(9):997-999. PMID: 31495411; PMCID: PMC7039340.
      Citations: 2     Fields:    Translation:Humans
    41. Cotter TG, Paul S, Couri T, Bodzin AS, Little EC, Sundaram V, Charlton M, Sandikçi B. Increasing Utilization and Excellent Initial Outcomes Following Liver Transplant of Hepatitis C Virus (HCV)-Viremic Donors Into HCV-Negative Recipients: Outcomes Following Liver Transplant of HCV-Viremic Donors. Hepatology. 2019 06; 69(6):2381-2395. PMID: 30706517.
      Citations: 34     Fields:    Translation:HumansCells
    42. Cotter TG, Paul S, Couri T, Bodzin AS, Little EC, Sundaram V, Charlton M, Sandikçi B. Improved Graft Survival After Liver Transplantation for Recipients With Hepatitis C Virus in the Direct-Acting Antiviral Era. Liver Transpl. 2019 04; 25(4):598-609. PMID: 30716208.
      Citations: 24     Fields:    Translation:HumansCells
    43. Pillai A, Couri T, Charlton M. Liver Allocation Policies in the USA: Past, Present, and the Future. Dig Dis Sci. 2019 04; 64(4):985-992. PMID: 30895482.
      Citations: 6     Fields:    Translation:Humans
    44. Charlton MR, Gane EJ, Shukla A, Dashtseren B, Duger D, Muljono DH, Payawal DA, Jargalsaikhan G, Purnomo HD, Cua IH, Hasan I, Sollano J, Win KM, Lesmana LA, Salih M, Thi Thu Thuy P, Shankar R, Saraswat VA. International Liver Transplantation Society Asian Consensus on the Management of Hepatitis C Virus Infection in Resource Limited Setting-From Noncirrhotic to Decompensated Disease and After Liver Transplantation. Transplantation. 2019 04; 103(4):733-746. PMID: 30335692.
      Citations: 1     Fields:    Translation:HumansCells
    45. Cotter TG, Charlton MR. The Triumph of Bacchus: The Emergence of Nonalcoholic Steatohepatitis and Alcoholic Liver Disease as the Leading Causes of Mortality From Cirrhosis. Hepatology. 2019 03; 69(3):931-933. PMID: 30570159.
      Citations: 3     Fields:    Translation:Humans
    46. Paul S, Charlton M. Liver Transplantation for Nonalcoholic Steatohepatitis: New Evidence of a Profound Increase Across Age Cohorts. Transplantation. 2019 01; 103(1):1-2. PMID: 30399124.
      Citations:    Fields:    Translation:Humans
    47. Jayakumar S, Middleton MS, Lawitz EJ, Mantry PS, Caldwell SH, Arnold H, Mae Diehl A, Ghalib R, Elkhashab M, Abdelmalek MF, Kowdley KV, Stephen Djedjos C, Xu R, Han L, Mani Subramanian G, Myers RP, Goodman ZD, Afdhal NH, Charlton MR, Sirlin CB, Loomba R. Longitudinal correlations between MRE, MRI-PDFF, and liver histology in patients with non-alcoholic steatohepatitis: Analysis of data from a phase II trial of selonsertib. J Hepatol. 2019 01; 70(1):133-141. PMID: 30291868.
      Citations: 85     Fields:    Translation:HumansCTClinical Trials
    48. Loomba R, Kayali Z, Noureddin M, Ruane P, Lawitz EJ, Bennett M, Wang L, Harting E, Tarrant JM, McColgan BJ, Chung C, Ray AS, Subramanian GM, Myers RP, Middleton MS, Lai M, Charlton M, Harrison SA. GS-0976 Reduces Hepatic Steatosis and Fibrosis Markers in Patients With Nonalcoholic Fatty Liver Disease. Gastroenterology. 2018 11; 155(5):1463-1473.e6. PMID: 30059671; PMCID: PMC6318218.
      Citations: 122     Fields:    Translation:HumansCTClinical Trials
    49. Younossi ZM, Loomba R, Rinella ME, Bugianesi E, Neuschwander-Tetri BA, Serfaty L, Negro F, Caldwell SH, Corey KE, Friedman SL, Abdelmalek MF, Harrison SA, Sanyal AJ, Lavine JE, Charlton MR, Chalasani NP, Anstee QM, Kowdley KV, George J, Goodman ZD, Lindor K, Marchesini G, Ratziu V, Mathurin P. Current and future therapeutic regimens for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Hepatology. 2018 07; 68(1):361-371. PMID: 29222911; PMCID: PMC6508084.
      Citations: 135     Fields:    Translation:Humans
    50. Younossi ZM, Loomba R, Anstee QM, Rinella ME, Marchesini G, Neuschwander-Tetri BA, Serfaty L, Negro F, Ratziu V, Corey KE, Friedman SL, Abdelmalek MF, Harrison SA, Sanyal AJ, Mathurin P, Charlton MR, Goodman ZD, Chalasani NP, Kowdley KV, George J, Lindor K, Bugianesi E, Caldwell SH, Lavine JE. Diagnostic modalities for nonalcoholic fatty liver disease, nonalcoholic steatohepatitis, and associated fibrosis. Hepatology. 2018 07; 68(1):349-360. PMID: 29222917; PMCID: PMC6511364.
      Citations: 144     Fields:    Translation:Humans
    51. Charlton M, Levitsky J, Aqel B, O'Grady J, Hemibach J, Rinella M, Fung J, Ghabril M, Thomason R, Burra P, Little EC, Shaked A, Trotter J, Roberts J, Rodriguez-Davalos M, Rela M, Pomfret E, Heyrend C, Gallegos-Orozco J, Berenguer M, Saliba F. International Liver Transplantation Society Consensus Statement on Immunosuppression in Liver Transplant Recipients. Transplantation. 2018 05; 102(5):727-743. PMID: 29485508.
      Citations: 67     Fields:    Translation:Humans
    52. Sundaram V, Jalan R, Ahn JC, Charlton MR, Goldberg DS, Karvellas CJ, Noureddin M, Wong RJ. Class III obesity is a risk factor for the development of acute-on-chronic liver failure in patients with decompensated cirrhosis. J Hepatol. 2018 09; 69(3):617-625. PMID: 29709681.
      Citations: 27     Fields:    Translation:Humans
    53. Charlton M. Risk of Hepatocellular Carcinoma in Patients With Nonalcoholic Steatohepatitis. Gastroenterol Hepatol (N Y). 2018 Apr; 14(4):247-249. PMID: 29942224; PMCID: PMC6009190.
      Citations: 3     
    54. Wongjarupong N, Negron-Ocasio GM, Chaiteerakij R, Addissie BD, Mohamed EA, Mara KC, Harmsen WS, Theobald JP, Peters BE, Balsanek JG, Ward MM, Giama NH, Venkatesh SK, Harnois DM, Charlton MR, Yamada H, Algeciras-Schimnich A, Snyder MR, Therneau TM, Roberts LR. Model combining pre-transplant tumor biomarkers and tumor size shows more utility in predicting hepatocellular carcinoma recurrence and survival than the BALAD models. World J Gastroenterol. 2018 Mar 28; 24(12):1321-1331. PMID: 29599607; PMCID: PMC5871827.
      Citations: 9     Fields:    Translation:Humans
    55. El-Sherif O, Jiang ZG, Tapper EB, Huang KC, Zhong A, Osinusi A, Charlton M, Manns M, Afdhal NH, Mukamal K, McHutchison J, Brainard DM, Terrault N, Curry MP. Baseline Factors Associated With Improvements in Decompensated Cirrhosis After Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection. Gastroenterology. 2018 06; 154(8):2111-2121.e8. PMID: 29535028.
      Citations: 39     Fields:    Translation:HumansCells
    56. Charlton M. FGF-19 agonism for NASH: a short study of a long disease. Lancet. 2018 03 24; 391(10126):1124-1126. PMID: 29519501.
      Citations: 4     Fields:    Translation:Humans
    57. Younossi ZM, Stepanova M, Lawitz E, Charlton M, Loomba R, Myers RP, Subramanian M, McHutchison JG, Goodman Z. Improvement of hepatic fibrosis and patient-reported outcomes in non-alcoholic steatohepatitis treated with selonsertib. Liver Int. 2018 10; 38(10):1849-1859. PMID: 29377462.
      Citations: 34     Fields:    Translation:HumansCTClinical Trials
    58. Massoud O, Charlton M. Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis and Hepatocellular Carcinoma. Clin Liver Dis. 2018 02; 22(1):201-211. PMID: 29128057.
      Citations: 36     Fields:    Translation:HumansPHPublic Health
    59. Loomba R, Gindin Y, Jiang Z, Lawitz E, Caldwell S, Djedjos CS, Xu R, Chung C, Myers RP, Subramanian GM, Goodman Z, Charlton M, Afdhal NH, Diehl AM. DNA methylation signatures reflect aging in patients with nonalcoholic steatohepatitis. JCI Insight. 2018 01 25; 3(2). PMID: 29367468; PMCID: PMC5821203.
      Citations: 25     Fields:    Translation:HumansCells
    60. Loomba R, Lawitz E, Mantry PS, Jayakumar S, Caldwell SH, Arnold H, Diehl AM, Djedjos CS, Han L, Myers RP, Subramanian GM, McHutchison JG, Goodman ZD, Afdhal NH, Charlton MR, GS-US-384-1497 Investigators. The ASK1 inhibitor selonsertib in patients with nonalcoholic steatohepatitis: A randomized, phase 2 trial. Hepatology. 2018 02; 67(2):549-559. PMID: 28892558; PMCID: PMC5814892.
      Citations: 228     Fields:    Translation:HumansCTClinical Trials
    61. Brito Delgado A, Cohen D, Eng TY, Stanley DN, Shi Z, Charlton M, Gutiérrez AN. Modeling the target dose fall-off in IMRT and VMAT planning techniques for cervical SBRT. Med Dosim. 2018 Spring; 43(1):1-10. PMID: 29223302.
      Citations: 4     Fields:    Translation:Humans
    62. Charlton M, Rinella M, Patel D, McCague K, Heimbach J, Watt K. Everolimus Is Associated With Less Weight Gain Than Tacrolimus 2 Years After Liver Transplantation: Results of a Randomized Multicenter Study. Transplantation. 2017 12; 101(12):2873-2882. PMID: 28817434; PMCID: PMC5704647.
      Citations: 23     Fields:    Translation:HumansCells
    63. Chalasani N, Younossi Z, Lavine JE, Charlton M, Cusi K, Rinella M, Harrison SA, Brunt EM, Sanyal AJ. The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases. Hepatology. 2018 01; 67(1):328-357. PMID: 28714183.
      Citations: 2305     Fields:    Translation:HumansPHPublic Health
    64. Levitsky J, Formica RN, Bloom RD, Charlton M, Curry M, Friedewald J, Friedman J, Goldberg D, Hall S, Ison M, Kaiser T, Klassen D, Klintmalm G, Kobashigawa J, Liapakis A, O'Conner K, Reese P, Stewart D, Terrault N, Theodoropoulos N, Trotter J, Verna E, Volk M. The American Society of Transplantation Consensus Conference on the Use of Hepatitis C Viremic Donors in Solid Organ Transplantation. Am J Transplant. 2017 Nov; 17(11):2790-2802. PMID: 28556422.
      Citations: 78     Fields:    Translation:HumansCells
    65. Terrault NA, McCaughan GW, Curry MP, Gane E, Fagiuoli S, Fung JYY, Agarwal K, Lilly L, Strasser SI, Brown KA, Gadano A, Kwo PY, Burra P, Samuel D, Charlton M, Pessoa MG, Berenguer M. International Liver Transplantation Society Consensus Statement on Hepatitis C Management in Liver Transplant Candidates. Transplantation. 2017 05; 101(5):945-955. PMID: 28437387.
      Citations: 18     Fields:    Translation:Humans
    66. Berenguer M, Strasser SI, Gadano A, Lilly L, Samuel D, Kwo PY, Agarwal K, Curry MP, Fagiuoli S, Fung JYY, Gane E, Brown KA, Burra P, Charlton M, Pessoa MG, McCaughan GW, Terrault NA. International Liver Transplantation Society Consensus Statement on Hepatitis C Management in Liver Transplant Recipients. Transplantation. 2017 05; 101(5):956-967. PMID: 28437388.
      Citations: 8     Fields:    Translation:Humans
    67. Afdhal N, Everson GT, Calleja JL, McCaughan GW, Bosch J, Brainard DM, McHutchison JG, De-Oertel S, An D, Charlton M, Reddy KR, Gane E, Curry MP, Forns X, Asselah T. Effect of viral suppression on hepatic venous pressure gradient in hepatitis C with cirrhosis and portal hypertension. J Viral Hepat. 2017 10; 24(10):823-831. PMID: 28295923.
      Citations: 35     Fields:    Translation:HumansCells
    68. Terrault N, Berenguer M, Strasser S, Gadano A, Lilly L, Samuel D, Kwo PY, Agarwal K, Curry M, Fagiuoli S, Fung JY, Gane E, Brown KA, Burra P, Charlton M, Pessoa M, McCaughan GW. International Liver Transplant Society Consensus Statement on HEPATITIS C MANAGEMENT IN LIVER TRANSPLANT RECIPIENTS. Transplantation. 2017 Mar 01. PMID: 28252566.
      Citations:    
    69. Terrault NA, McCaughan GW, Curry MP, Gane E, Fagiuoli S, Fung J, Agarwal K, Lilly L, Strasser SI, Brown K, Gadano A, Kwo PY, Burra P, Samuel D, Charlton M, Pessoa MG, Berenguer M. International Liver Transplant Society Consensus Statement on HEPATITIS C MANAGEMENT IN LIVER TRANSPLANT CANDIDATES. Transplantation. 2017 Mar 01. PMID: 28252565.
      Citations:    
    70. Krishnan A, Abdullah TS, Mounajjed T, Hartono S, McConico A, White T, LeBrasseur N, Lanza I, Nair S, Gores G, Charlton M. A longitudinal study of whole body, tissue, and cellular physiology in a mouse model of fibrosing NASH with high fidelity to the human condition. Am J Physiol Gastrointest Liver Physiol. 2017 Jun 01; 312(6):G666-G680. PMID: 28232454; PMCID: PMC6146305.
      Citations: 39     Fields:    Translation:HumansAnimalsCells
    71. Gallegos-Orozco JF, Charlton MR. Predictors of Cardiovascular Events After Liver Transplantation. Clin Liver Dis. 2017 05; 21(2):367-379. PMID: 28364819.
      Citations: 5     Fields:    Translation:Humans
    72. Goldberg D, Ditah IC, Saeian K, Lalehzari M, Aronsohn A, Gorospe EC, Charlton M. Changes in the Prevalence of Hepatitis C Virus Infection, Nonalcoholic Steatohepatitis, and Alcoholic Liver Disease Among Patients With Cirrhosis or Liver Failure on the Waitlist for Liver Transplantation. Gastroenterology. 2017 04; 152(5):1090-1099.e1. PMID: 28088461; PMCID: PMC5367965.
      Citations: 223     Fields:    Translation:HumansCells
    73. Younossi ZM, Stepanova M, Feld J, Zeuzem S, Sulkowski M, Foster GR, Mangia A, Charlton M, O'Leary JG, Curry MP, Nader F, Henry L, Hunt S. Sofosbuvir and Velpatasvir Combination Improves Patient-reported Outcomes for Patients With HCV Infection, Without or With Compensated or Decompensated Cirrhosis. Clin Gastroenterol Hepatol. 2017 03; 15(3):421-430.e6. PMID: 27847279.
      Citations: 17     Fields:    Translation:Humans
    74. Charlton MR. Roadmap for improving patient and graft survival in the next 10 years. Liver Transpl. 2016 11; 22(S1):71-78. PMID: 27514705.
      Citations: 7     Fields:    Translation:Humans
    75. Goldberg DA, Gilroy R, Charlton M. New organ allocation policy in liver transplantation in the United States. Clin Liver Dis (Hoboken). 2016 Oct; 8(4):108-112. PMID: 31041075; PMCID: PMC6490206.
      Citations: 1     
    76. Samadder NJ, Smith KR, Wong J, Hanson H, Boucher K, Burt RW, Charlton M, Byrne KR, Gallegos-Orozco JF, Koptiuch C, Curtin K. Familial Risk of Biliary Tract Cancers: A Population-Based Study in Utah. Dig Dis Sci. 2016 12; 61(12):3627-3632. PMID: 27655103.
      Citations: 2     Fields:    Translation:Humans
    77. Younossi ZM, Stepanova M, Charlton M, Curry MP, O'Leary JG, Brown RS, Hunt S. Patient-reported outcomes with sofosbuvir and velpatasvir with or without ribavirin for hepatitis C virus-related decompensated cirrhosis: an exploratory analysis from the randomised, open-label ASTRAL-4 phase 3 trial. Lancet Gastroenterol Hepatol. 2016 10; 1(2):122-132. PMID: 28404069.
      Citations: 23     Fields:    Translation:HumansCTClinical Trials
    78. Gallegos-Orozco JF, Charlton MR. Alcoholic Liver Disease and Liver Transplantation. Clin Liver Dis. 2016 08; 20(3):521-34. PMID: 27373614.
      Citations: 8     Fields:    Translation:Humans
    79. Gambato M, Hedskog C, Svarovskia ES, Brainard D, Denning J, Curry MP, Charlton M, Koutsoudakis G, Forns X, Pérez-Del-Pulgar S, Caro-Pérez N, Londoño MC. Hepatitis C Virus RNA Persists in Liver Explants of Most Patients Awaiting Liver Transplantation Treated With an Interferon-Free Regimen. Gastroenterology. 2016 10; 151(4):633-636.e3. PMID: 27373513.
      Citations: 8     Fields:    Translation:HumansCells
    80. O'Leary JG, Levitsky J, Wong F, Nadim MK, Charlton M, Kim WR. Protecting the Kidney in Liver Transplant Candidates: Practice-Based Recommendations From the American Society of Transplantation Liver and Intestine Community of Practice. Am J Transplant. 2016 09; 16(9):2516-31. PMID: 26990924.
      Citations: 22     Fields:    Translation:Humans
    81. Billerbeck E, Mommersteeg MC, Shlomai A, Xiao JW, Andrus L, Bhatta A, Vercauteren K, Michailidis E, Dorner M, Krishnan A, Charlton MR, Chiriboga L, Rice CM, de Jong YP. Humanized mice efficiently engrafted with fetal hepatoblasts and syngeneic immune cells develop human monocytes and NK cells. J Hepatol. 2016 08; 65(2):334-43. PMID: 27151182; PMCID: PMC4955758.
      Citations: 45     Fields:    Translation:HumansAnimalsCells
    82. Pham T, Dick TB, Charlton MR. Nonalcoholic Fatty Liver Disease and Liver Transplantation. Clin Liver Dis. 2016 May; 20(2):403-17. PMID: 27063277.
      Citations: 5     Fields:    Translation:Humans
    83. Curry MP, Charlton M. Sofosbuvir and Velpatasvir for Patients with HCV Infection. N Engl J Med. 2016 04 28; 374(17):1688. PMID: 27135094.
      Citations: 4     Fields:    Translation:HumansCells
    84. Fedoravicius A, Charlton M. Abnormal liver tests after liver transplantation. Clin Liver Dis (Hoboken). 2016 Apr; 7(4):73-79. PMID: 31041034; PMCID: PMC6490263.
      Citations: 7     
    85. Rinella M, Charlton M. The globalization of nonalcoholic fatty liver disease: Prevalence and impact on world health. Hepatology. 2016 07; 64(1):19-22. PMID: 26926530.
      Citations: 88     Fields:    Translation:Humans
    86. Siddiqui MS, Charlton M. Liver Transplantation for Alcoholic and Nonalcoholic Fatty Liver Disease: Pretransplant Selection and Posttransplant Management. Gastroenterology. 2016 06; 150(8):1849-62. PMID: 26971826.
      Citations: 9     Fields:    Translation:Humans
    87. Welzel TM, Reddy KR, Flamm SL, Denning J, Lin M, Hyland R, Pang PS, McHutchison JG, Charlton M, Everson GT, Zeuzem S, Afdhal N. On-treatment HCV RNA in patients with varying degrees of fibrosis and cirrhosis in the SOLAR-1 trial. Antivir Ther. 2016; 21(6):541-546. PMID: 26891418.
      Citations: 3     Fields:    Translation:HumansCellsCTClinical Trials
    88. Hirsova P, Ibrahim SH, Krishnan A, Verma VK, Bronk SF, Werneburg NW, Charlton MR, Shah VH, Malhi H, Gores GJ. Lipid-Induced Signaling Causes Release of Inflammatory Extracellular Vesicles From Hepatocytes. Gastroenterology. 2016 Apr; 150(4):956-67. PMID: 26764184; PMCID: PMC4808464.
      Citations: 224     Fields:    Translation:HumansAnimalsCells
    89. Rinella ME, Lominadze Z, Loomba R, Charlton M, Neuschwander-Tetri BA, Caldwell SH, Kowdley K, Harrison SA. Practice patterns in NAFLD and NASH: real life differs from published guidelines. Therap Adv Gastroenterol. 2016 Jan; 9(1):4-12. PMID: 26770262; PMCID: PMC4699276.
      Citations: 32     
    90. Goldberg DS, Charlton M. Usefulness of Liver Transplantation in the Elderly: The Converging Impact of Risk and Benefit. Gastroenterology. 2016 Feb; 150(2):306-9. PMID: 26710989.
      Citations: 5     Fields:    Translation:Humans
    91. Dhanasekaran R, Sanchez W, Charlton M. Response to Fibrosis progression in patients treated for hepatitis C recurrence. Liver Int. 2015 Dec; 35(12):2625. PMID: 26386267.
      Citations:    Fields:    Translation:Humans
    92. Curry MP, O'Leary JG, Bzowej N, Muir AJ, Korenblat KM, Fenkel JM, Reddy KR, Lawitz E, Flamm SL, Schiano T, Teperman L, Fontana R, Schiff E, Fried M, Doehle B, An D, McNally J, Osinusi A, Brainard DM, McHutchison JG, Brown RS, Charlton M, ASTRAL-4 Investigators. Sofosbuvir and Velpatasvir for HCV in Patients with Decompensated Cirrhosis. N Engl J Med. 2015 Dec 31; 373(27):2618-28. PMID: 26569658.
      Citations: 261     Fields:    Translation:HumansCellsCTClinical Trials
    93. Sundaram V, Kaung A, Rajaram A, Lu SC, Tran TT, Nissen NN, Klein AS, Jalan R, Charlton MR, Jeon CY. Obesity is independently associated with infection in hospitalised patients with end-stage liver disease. Aliment Pharmacol Ther. 2015 Dec; 42(11-12):1271-80. PMID: 26510540.
      Citations: 13     Fields:    Translation:Humans
    94. Ditah I, Charlton M. Genetic susceptibility to hepatitis E viral infection: An enigmatic virus gives up a secret. Hepatology. 2015 Nov; 62(5):1337-8. PMID: 26250990.
      Citations: 1     Fields:    Translation:Humans
    95. Dick TB, Lindberg LS, Ramirez DD, Charlton MR. A clinician's guide to drug-drug interactions with direct-acting antiviral agents for the treatment of hepatitis C viral infection. Hepatology. 2016 Feb; 63(2):634-43. PMID: 26033675.
      Citations: 14     Fields:    Translation:Humans
    96. Koning L, Charlton MR, Pas SD, Heimbach JK, Osterhaus AD, Watt KD, Janssen HL, de Knegt RJ, van der Eijk AA. Prevalence and clinical consequences of Hepatitis E in patients who underwent liver transplantation for chronic Hepatitis C in the United States. BMC Infect Dis. 2015 Sep 02; 15:371. PMID: 26328802; PMCID: PMC4557757.
      Citations: 12     Fields:    Translation:HumansCells
    97. Ghabril M, Charlton M. Lack of Survival Benefit Following Liver Transplantation With MELD Exception Points for Hepatocellular Carcinoma: Beyond the Unblinding of Lady Justice. Gastroenterology. 2015 Sep; 149(3):531-4. PMID: 26226568.
      Citations: 3     Fields:    Translation:Humans
    98. Dhanasekaran R, Sanchez W, Mounajjed T, Wiesner RH, Watt KD, Charlton MR. Impact of fibrosis progression on clinical outcome in patients treated for post-transplant hepatitis C recurrence. Liver Int. 2015 Nov; 35(11):2433-41. PMID: 26058570.
      Citations: 10     Fields:    Translation:HumansCells
    99. Charlton M, Everson GT, Flamm SL, Kumar P, Landis C, Brown RS, Fried MW, Terrault NA, O'Leary JG, Vargas HE, Kuo A, Schiff E, Sulkowski MS, Gilroy R, Watt KD, Brown K, Kwo P, Pungpapong S, Korenblat KM, Muir AJ, Teperman L, Fontana RJ, Denning J, Arterburn S, Dvory-Sobol H, Brandt-Sarif T, Pang PS, McHutchison JG, Reddy KR, Afdhal N, SOLAR-1 Investigators. Ledipasvir and Sofosbuvir Plus Ribavirin for Treatment of HCV Infection in Patients With Advanced Liver Disease. Gastroenterology. 2015 Sep; 149(3):649-59. PMID: 25985734.
      Citations: 261     Fields:    Translation:HumansCellsCTClinical Trials
    100. Chaiteerakij R, Zhang X, Addissie BD, Mohamed EA, Harmsen WS, Theobald PJ, Peters BE, Balsanek JG, Ward MM, Giama NH, Moser CD, Oseini AM, Umeda N, Venkatesh S, Harnois DM, Charlton MR, Yamada H, Satomura S, Algeciras-Schimnich A, Snyder MR, Therneau TM, Roberts LR. Combinations of biomarkers and Milan criteria for predicting hepatocellular carcinoma recurrence after liver transplantation. Liver Transpl. 2015 May; 21(5):599-606. PMID: 25789635; PMCID: PMC4490162.
      Citations: 44     Fields:    Translation:HumansCells
    101. Forns X, Charlton M, Denning J, McHutchison JG, Symonds WT, Brainard D, Brandt-Sarif T, Chang P, Kivett V, Fontana RJ, Baumert TF, Coilly A, Castells L, Prieto M, Londoño MC, Habersetzer F. Sofosbuvir compassionate use program for patients with severe recurrent hepatitis C after liver transplantation. Hepatology. 2015 May; 61(5):1485-94. PMID: 25557906.
      Citations: 63     Fields:    Translation:HumansCTClinical Trials
    102. Charlton M. Reply: To PMID 24824965. Hepatology. 2015 Apr; 61(4):1442-3. PMID: 25598196.
      Citations:    Fields:    Translation:Humans
    103. Ditah I, Al Bawardy B, Gonzalez HC, Saberi B, Ditah C, Kamath PS, Charlton M. Lack of health insurance limits the benefits of hepatitis C virus screening: insights from the National Health and Nutrition Examination Hepatitis C follow-up study. Am J Gastroenterol. 2015 Aug; 110(8):1126-33. PMID: 25756239.
      Citations: 17     Fields:    Translation:HumansPHPublic Health
    104. Terzi E, Ray Kim W, Sanchez W, Charlton MR, Schmeltzer P, Gores GJ, Andrews JC, Smyrk TC, Heimbach JK. Impact of multiple transarterial chemoembolization treatments on hepatocellular carcinoma for patients awaiting liver transplantation. Liver Transpl. 2015 Feb; 21(2):248-57. PMID: 25371111.
      Citations: 8     Fields:    Translation:Humans
    105. Gallegos-Orozco JF, Charlton MR. Treatment of HCV prior to liver transplantation to prevent HCV recurrence - wise or wasteful? Liver Int. 2015 Jan; 35(1):9-11. PMID: 25412996.
      Citations: 1     Fields:    Translation:Humans
    106. Musso G, Tabibian JH, Charlton M. Chronic kidney disease (CKD) and NAFLD: time for awareness and screening. J Hepatol. 2015 Apr; 62(4):983-4. PMID: 25529627.
      Citations: 5     Fields:    Translation:Humans
    107. Hines CS, Ray K, Schmidt JJ, Xiong F, Feenstra RW, Pras-Raves M, de Moes JP, Lange JH, Melikishvili M, Fried MG, Mortenson P, Charlton M, Patel Y, Courtney SM, Kruse CG, Rodgers DW. Allosteric inhibition of the neuropeptidase neurolysin. J Biol Chem. 2014 Dec 19; 289(51):35605-19. PMID: 25378390; PMCID: PMC4271243.
      Citations: 10     Fields:    Translation:AnimalsCells
    108. Charlton M, Gane E, Manns MP, Brown RS, Curry MP, Kwo PY, Fontana RJ, Gilroy R, Teperman L, Muir AJ, McHutchison JG, Symonds WT, Brainard D, Kirby B, Dvory-Sobol H, Denning J, Arterburn S, Forns X, Terrault NA, Samuel D. Sofosbuvir and ribavirin for treatment of compensated recurrent hepatitis C virus infection after liver transplantation. Gastroenterology. 2015 Jan; 148(1):108-17. PMID: 25304641.
      Citations: 115     Fields:    Translation:HumansCellsCTClinical Trials
    109. de Jong YP, Dorner M, Mommersteeg MC, Xiao JW, Balazs AB, Robbins JB, Winer BY, Gerges S, Vega K, Labitt RN, Donovan BM, Giang E, Krishnan A, Chiriboga L, Charlton MR, Burton DR, Baltimore D, Law M, Rice CM, Ploss A. Broadly neutralizing antibodies abrogate established hepatitis C virus infection. Sci Transl Med. 2014 Sep 17; 6(254):254ra129. PMID: 25232181; PMCID: PMC4312107.
      Citations: 135     Fields:    Translation:HumansAnimalsCells
    110. Charlton MR. Improving long-term outcomes after liver transplantation. Clin Liver Dis. 2014 Aug; 18(3):717-30. PMID: 25017085.
      Citations: 5     Fields:    Translation:Humans
    111. Musso G, Gambino R, Tabibian JH, Hamaguchi M, Hultcrantz R, Yoon SK, Charatcharoenwitthaya P, George J, Barrera F, Armstrong MJ, Hopkins LJ, Gao X, Francque S, Verrijken A, Yilmaz Y, Lindor KD, Charlton M, Haring R, Lerch MM, Rettig R, Ryu S, Li G, Wong LL, Machado M, Cortez-Pinto H, Yasui K, Cassader M, Ekstedt M, Kechagias S, Hagström H, Hafliðadóttir S, Björnsson ES, Völzke H. Association of non-alcoholic fatty liver disease with chronic kidney disease: a systematic review and meta-analysis. PLoS Med. 2014 Jul; 11(7):e1001680. PMID: 25050550; PMCID: PMC4106719.
      Citations: 243     Fields:    Translation:Humans
    112. Ditah I, Ditah F, Devaki P, Ditah C, Kamath PS, Charlton M. Current epidemiology of hepatitis E virus infection in the United States: low seroprevalence in the National Health and Nutrition Evaluation Survey. Hepatology. 2014 Sep; 60(3):815-22. PMID: 24824965.
      Citations: 36     Fields:    Translation:Humans
    113. Aull MJ, Afaneh C, Charlton M, Serur D, Douglas M, Christos PJ, Kapur S, Del Pizzo JJ. A randomized, prospective, parallel group study of laparoscopic versus laparoendoscopic single site donor nephrectomy for kidney donation. Am J Transplant. 2014 Jul; 14(7):1630-7. PMID: 24934732; PMCID: PMC4274784.
      Citations: 8     Fields:    Translation:Humans
    114. Watt KD, Fan C, Therneau T, Heimbach JK, Seaberg EC, Charlton MR. Serum adipokine and inflammatory markers before and after liver transplantation in recipients with major cardiovascular events. Liver Transpl. 2014 Jul; 20(7):791-7. PMID: 24692322; PMCID: PMC4072743.
      Citations: 8     Fields:    Translation:Humans
    115. Kim DJ, Clark PJ, Heimbach J, Rosen C, Sanchez W, Watt K, Charlton MR. Recurrence of hepatocellular carcinoma: importance of mRECIST response to chemoembolization and tumor size. Am J Transplant. 2014 Jun; 14(6):1383-90. PMID: 24801862.
      Citations: 36     Fields:    Translation:Humans
    116. Rinella ME, Loomba R, Caldwell SH, Kowdley K, Charlton M, Tetri B, Harrison SA. Controversies in the Diagnosis and Management of NAFLD and NASH. Gastroenterol Hepatol (N Y). 2014 Apr; 10(4):219-27. PMID: 24976805; PMCID: PMC4073533.
      Citations: 30     
    117. Guichelaar MM, Charlton MR. Decreased muscle mass in nonalcoholic fatty liver disease: new evidence of a link between growth hormone and fatty liver disease? Hepatology. 2014 May; 59(5):1668-70. PMID: 24691865.
      Citations: 6     Fields:    Translation:Humans
    118. Al-Bawardy B, Kim WR, Poterucha JJ, Gross JB, Charlton MR, Larson JJ, Colby CL, Canterbury K, Warner J, Therneau TM. Comparative effectiveness of telaprevir-based triple therapy in patients with chronic hepatitis C. Mayo Clin Proc. 2014 May; 89(5):595-601. PMID: 24661475; PMCID: PMC4160303.
      Citations:    Fields:    Translation:Humans
    119. Duarte-Rojo A, Budhraja V, Veldt BJ, Goldstein DD, Watt KD, Heimbach JK, McHutchison JG, Tillman HL, Poterucha JJ, Charlton MR. Interleukin-28B and fibrosing cholestatic hepatitis in posttransplant hepatitis C: a case-control study and literature review. Liver Transpl. 2013 Dec; 19(12):1311-7. PMID: 24039107.
      Citations: 8     Fields:    Translation:Humans
    120. Ditah I, Ditah F, Devaki P, Ewelukwa O, Ditah C, Njei B, Luma HN, Charlton M. The changing epidemiology of hepatitis C virus infection in the United States: National Health and Nutrition Examination Survey 2001 through 2010. J Hepatol. 2014 Apr; 60(4):691-8. PMID: 24291324.
      Citations: 82     Fields:    Translation:Humans
    121. Fussner LA, Charlton MR, Heimbach JK, Fan C, Dierkhising R, Coss E, Watt KD. The impact of gender and NASH on chronic kidney disease before and after liver transplantation. Liver Int. 2014 Sep; 34(8):1259-66. PMID: 24262002.
      Citations: 21     Fields:    Translation:Humans
    122. Goergen SK, Ang H, Wong F, Carse EA, Charlton M, Evans R, Whiteley G, Clark J, Shipp D, Jolley D, Paul E, Cheong JL. Early MRI in term infants with perinatal hypoxic-ischaemic brain injury: interobserver agreement and MRI predictors of outcome at 2 years. Clin Radiol. 2014 Jan; 69(1):72-81. PMID: 24210250.
      Citations: 25     Fields:    Translation:Humans
    123. Charlton MR. How important is acute cellular rejection? Liver Transpl. 2013 Nov; 19 Suppl 2:S9-13. PMID: 24019169.
      Citations:    Fields:    Translation:HumansCells
    124. Charlton M, Dick T. Victory and defeat at Heraclea - treating hepatitis C infection following liver transplantation with telaprevir and boceprevir. J Hepatol. 2014 Jan; 60(1):6-8. PMID: 24128417.
      Citations: 1     Fields:    Translation:Humans
    125. Charlton M. The lethal and enduring inequity of deceased donor liver allocation policy for hepatocellular carcinoma in the United States. Am J Transplant. 2013 Nov; 13(11):2794-6. PMID: 24119018.
      Citations:    Fields:    Translation:Humans
    126. Yamada S, Kawaguchi A, Kawaguchi T, Fukushima N, Kuromatsu R, Sumie S, Takata A, Nakano M, Satani M, Tonan T, Fujimoto K, Shima H, Kakuma T, Torimura T, Charlton MR, Sata M. Serum albumin level is a notable profiling factor for non-B, non-C hepatitis virus-related hepatocellular carcinoma: A data-mining analysis. Hepatol Res. 2014 Aug; 44(8):837-45. PMID: 23819517.
      Citations: 12     
    127. Charlton MR. Sirolimus as a calcineurin inhibitor- and renal-sparing agent: all good things come to those who wait versus spare the nephron, spoil the patient. Liver Transpl. 2013 Aug; 19(8):787-9. PMID: 23813776.
      Citations:    Fields:    Translation:Humans
    128. Perrillo R, Buti M, Durand F, Charlton M, Gadano A, Cantisani G, Loong CC, Brown K, Hu W, Lopez-Talavera JC, Llamoso C. Entecavir and hepatitis B immune globulin in patients undergoing liver transplantation for chronic hepatitis B. Liver Transpl. 2013 Aug; 19(8):887-95. PMID: 23788462; PMCID: PMC3791551.
      Citations: 15     Fields:    Translation:HumansCellsCTClinical Trials
    129. Watt KD, Dierkhising R, Fan C, Heimbach JK, Tillman H, Goldstein D, Thompson A, Krishnan A, Charlton MR. Investigation of PNPLA3 and IL28B genotypes on diabetes and obesity after liver transplantation: insight into mechanisms of disease. Am J Transplant. 2013 Sep; 13(9):2450-7. PMID: 23859071.
      Citations: 20     Fields:    Translation:Humans
    130. Bhat M, Charlton M. Preserving flow in liver transplant recipients: mTOR inhibitors everolimus and sirolimus are not peas from a pod. Am J Transplant. 2013 Jul; 13(7):1633-5. PMID: 23802724.
      Citations: 2     Fields:    Translation:Humans
    131. Singal AK, Kamath PS, Francisco Ziller N, DiCecco S, Shoreibah M, Kremers W, Charlton MR, Heimbach JK, Watt KD, Shah VH. Nutritional status of patients with alcoholic cirrhosis undergoing liver transplantation: time trends and impact on survival. Transpl Int. 2013 Aug; 26(8):788-94. PMID: 23751180; PMCID: PMC3987667.
      Citations: 15     Fields:    Translation:Humans
    132. Pungpapong S, Aqel BA, Koning L, Murphy JL, Henry TM, Ryland KL, Yataco ML, Satyanarayana R, Rosser BG, Vargas HE, Charlton MR, Keaveny AP. Multicenter experience using telaprevir or boceprevir with peginterferon and ribavirin to treat hepatitis C genotype 1 after liver transplantation. Liver Transpl. 2013 Jul; 19(7):690-700. PMID: 23696372.
      Citations: 32     Fields:    Translation:HumansCTClinical Trials
    133. Charlton M. Evolving aspects of liver transplantation for nonalcoholic steatohepatitis. Curr Opin Organ Transplant. 2013 Jun; 18(3):251-8. PMID: 23652610.
      Citations: 21     Fields:    Translation:Humans
    134. Guichelaar MM, Gawrieh S, Olivier M, Viker K, Krishnan A, Sanderson S, Malinchoc M, Watt KD, Swain JM, Sarr M, Charlton MR. Interactions of allelic variance of PNPLA3 with nongenetic factors in predicting nonalcoholic steatohepatitis and nonhepatic complications of severe obesity. Obesity (Silver Spring). 2013 Sep; 21(9):1935-41. PMID: 23418085; PMCID: PMC3896123.
      Citations: 14     Fields:    Translation:Humans
    135. Topazian M, Levy MJ, Patel S, Charlton MR, Baron TH. Hepatic artery pseudoaneurysm formation following intraductal biliary radiofrequency ablation. Endoscopy. 2013; 45 Suppl 2 UCTN:E161-2. PMID: 23716112.
      Citations: 7     Fields:    Translation:Humans
    136. Charlton MR. ChREBP in NASH - a liver transcription factor comes in from the cold. J Hepatol. 2013 Jul; 59(1):178-9. PMID: 23523581.
      Citations: 3     Fields:    Translation:HumansAnimalsCells
    137. Duarte-Rojo A, Deneke MG, Charlton MR. Interleukin-28B polymorphism in hepatitis C and liver transplantation. Liver Transpl. 2013 Jan; 19(1):49-58. PMID: 23008132.
      Citations: 9     Fields:    Translation:Humans
    138. Pate W, Charlton M, Wellington C. Measurement and analysis of 8-hour time-weighted average sound pressure levels in a vivarium decontamination facility. Arch Environ Occup Health. 2013; 68(3):173-9. PMID: 23566325.
      Citations:    Fields:    Translation:HumansPHPublic Health
    139. Heimbach JK, Watt KD, Poterucha JJ, Ziller NF, Cecco SD, Charlton MR, Hay JE, Wiesner RH, Sanchez W, Rosen CB, Swain JM. Combined liver transplantation and gastric sleeve resection for patients with medically complicated obesity and end-stage liver disease. Am J Transplant. 2013 Feb; 13(2):363-8. PMID: 23137119.
      Citations: 61     Fields:    Translation:Humans
    140. Singal AK, Charlton MR. Nutrition in alcoholic liver disease. Clin Liver Dis. 2012 Nov; 16(4):805-26. PMID: 23101983.
      Citations: 28     Fields:    Translation:Humans
    141. Krishnan A, Li X, Kao WY, Viker K, Butters K, Masuoka H, Knudsen B, Gores G, Charlton M. Lumican, an extracellular matrix proteoglycan, is a novel requisite for hepatic fibrosis. Lab Invest. 2012 Dec; 92(12):1712-25. PMID: 23007134; PMCID: PMC3810270.
      Citations: 65     Fields:    Translation:HumansAnimalsCells
    142. Porres-Aguilar M, Altamirano JT, Torre-Delgadillo A, Charlton MR, Duarte-Rojo A. Portopulmonary hypertension and hepatopulmonary syndrome: a clinician-oriented overview. Eur Respir Rev. 2012 Sep 01; 21(125):223-33. PMID: 22941887; PMCID: PMC9487331.
      Citations: 33     Fields:    Translation:Humans
    143. Watt KD, Dierkhising R, Heimbach JK, Charlton MR. Impact of sirolimus and tacrolimus on mortality and graft loss in liver transplant recipients with or without hepatitis C virus: an analysis of the Scientific Registry of Transplant Recipients Database. Liver Transpl. 2012 Sep; 18(9):1029-36. PMID: 22641474.
      Citations: 17     Fields:    Translation:Humans
    144. Duarte-Rojo A, Veldt BJ, Goldstein DD, Tillman HL, Watt KD, Heimbach JK, McHutchison JG, Poterucha JJ, Vargas-Vorackova F, Charlton MR. The course of posttransplant hepatitis C infection: comparative impact of donor and recipient source of the favorable IL28B genotype and other variables. Transplantation. 2012 Jul 27; 94(2):197-203. PMID: 22766768.
      Citations: 22     Fields:    Translation:Humans
    145. Sembera S, Lammert C, Talwalkar JA, Sanderson SO, Poterucha JJ, Hay JE, Wiesner RH, Gores GJ, Rosen CB, Heimbach JK, Charlton MR. Frequency, clinical presentation, and outcomes of drug-induced liver injury after liver transplantation. Liver Transpl. 2012 Jul; 18(7):803-10. PMID: 22389256; PMCID: PMC3396746.
      Citations: 7     Fields:    Translation:Humans
    146. Urban T, Charlton MR, Goldstein DB. Introduction to the genetics and biology of interleukin-28B. Hepatology. 2012 Jul; 56(1):361-6. PMID: 22511448.
      Citations: 11     Fields:    Translation:HumansAnimalsCells
    147. Chalasani N, Younossi Z, Lavine JE, Diehl AM, Brunt EM, Cusi K, Charlton M, Sanyal AJ. The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology. 2012 Jun; 55(6):2005-23. PMID: 22488764.
      Citations: 1418     Fields:    Translation:Humans
    148. Chalasani N, Younossi Z, Lavine JE, Diehl AM, Brunt EM, Cusi K, Charlton M, Sanyal AJ, American Association for the Study of Liver Diseases, American College of Gastroenterology, American Gastroenterological Association. The diagnosis and management of non-alcoholic fatty liver disease: Practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Am J Gastroenterol. 2012 Jun; 107(6):811-26. PMID: 22641309.
      Citations: 170     Fields:    Translation:HumansPHPublic Health
    149. Chalasani N, Younossi Z, Lavine JE, Diehl AM, Brunt EM, Cusi K, Charlton M, Sanyal AJ, American Gastroenterological Association, American Association for the Study of Liver Diseases, American College of Gastroenterologyh. The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology. Gastroenterology. 2012 Jun; 142(7):1592-609. PMID: 22656328.
      Citations: 724     Fields:    Translation:Humans
    150. Adebajo CO, Talwalkar JA, Poterucha JJ, Kim WR, Charlton MR. Ultrasound-based transient elastography for the detection of hepatic fibrosis in patients with recurrent hepatitis C virus after liver transplantation: a systematic review and meta-analysis. Liver Transpl. 2012 Mar; 18(3):323-31. PMID: 22140010.
      Citations: 25     Fields:    Translation:Humans
    151. Veldt BJ, Duarte-Rojo A, Thompson AJ, Watt KD, Heimbach JK, Tillmann HL, Goldstein DD, McHutchison JG, Charlton MR. Recipient IL28B polymorphism is an important independent predictor of posttransplant diabetes mellitus in liver transplant patients with chronic hepatitis C. Am J Transplant. 2012 Mar; 12(3):737-44. PMID: 22300408.
      Citations: 9     Fields:    Translation:HumansCells
    152. Pasquinelli C, McPhee F, Eley T, Villegas C, Sandy K, Sheridan P, Persson A, Huang SP, Hernandez D, Sheaffer AK, Scola P, Marbury T, Lawitz E, Goldwater R, Rodriguez-Torres M, Demicco M, Wright D, Charlton M, Kraft WK, Lopez-Talavera JC, Grasela DM. Single- and multiple-ascending-dose studies of the NS3 protease inhibitor asunaprevir in subjects with or without chronic hepatitis C. Antimicrob Agents Chemother. 2012 Apr; 56(4):1838-44. PMID: 22290978; PMCID: PMC3318341.
      Citations: 14     Fields:    Translation:HumansCells
    153. Gawrieh S, Marion MC, Komorowski R, Wallace J, Charlton M, Kissebah A, Langefeld CD, Olivier M. Genetic variation in the peroxisome proliferator activated receptor-gamma gene is associated with histologically advanced NAFLD. Dig Dis Sci. 2012 Apr; 57(4):952-7. PMID: 22160635.
      Citations: 20     Fields:    Translation:Humans
    154. Davis GL, Teperman L, Netto GJ, Washburn K, Rudich SM, Pomfret EA, Vargas HE, Brown R, Eckhoff D, Pruett TL, Roberts J, Mulligan DC, Charlton MR, Heffron TG, Ham JM, Douglas DD, Sher L, Baliga PK, Kinkhabwala M, Koneru B, Abecassis M, Millis M, Jennings LW, Fasola CG, Klintmalm GB. A randomized, multicenter study comparing steroid-free immunosuppression and standard immunosuppression for liver transplant recipients with chronic hepatitis C. Liver Transpl. 2011 Dec; 17(12):1394-403. PMID: 21850690.
      Citations: 30     Fields:    Translation:HumansCells
    155. Weingarten TN, Swain JM, Kendrick ML, Charlton MR, Schroeder BJ, Lee RE, Narr BJ, Ribeiro TC, Schroeder DR, Sprung J. Nonalcoholic steatohepatitis (NASH) does not increase complications after laparoscopic bariatric surgery. Obes Surg. 2011 Nov; 21(11):1714-20. PMID: 21948267.
      Citations: 17     Fields:    Translation:Humans
    156. Charlton M, Leise MD. Boceprevir (Victrelis) for HCV: V is for victory and very complex. Hepatology. 2011 Nov; 54(5):1882-6. PMID: 22038791.
      Citations: 3     Fields:    
    157. Koehler E, Swain J, Sanderson S, Krishnan A, Watt K, Charlton M. Growth hormone, dehydroepiandrosterone and adiponectin levels in non-alcoholic steatohepatitis: an endocrine signature for advanced fibrosis in obese patients. Liver Int. 2012 Feb; 32(2):279-86. PMID: 22098614.
      Citations: 23     Fields:    Translation:Humans
    158. Charlton M, Krishnan A, Viker K, Sanderson S, Cazanave S, McConico A, Masuoko H, Gores G. Fast food diet mouse: novel small animal model of NASH with ballooning, progressive fibrosis, and high physiological fidelity to the human condition. Am J Physiol Gastrointest Liver Physiol. 2011 Nov; 301(5):G825-34. PMID: 21836057; PMCID: PMC3220319.
      Citations: 196     Fields:    Translation:AnimalsCells
    159. Charlton MR, Burns JM, Pedersen RA, Watt KD, Heimbach JK, Dierkhising RA. Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States. Gastroenterology. 2011 Oct; 141(4):1249-53. PMID: 21726509.
      Citations: 421     Fields:    Translation:Humans
    160. Charlton M. Telaprevir, boceprevir, cytochrome P450 and immunosuppressive agents--a potentially lethal cocktail. Hepatology. 2011 Jul; 54(1):3-5. PMID: 21710471.
      Citations: 28     Fields:    Translation:Humans
    161. Kawaguchi T, Izumi N, Charlton MR, Sata M. Branched-chain amino acids as pharmacological nutrients in chronic liver disease. Hepatology. 2011 Sep 02; 54(3):1063-70. PMID: 21563202.
      Citations: 113     Fields:    Translation:Humans
    162. Massoud O, Heimbach J, Viker K, Krishnan A, Poterucha J, Sanchez W, Watt K, Wiesner R, Charlton M. Noninvasive diagnosis of acute cellular rejection in liver transplant recipients: a proteomic signature validated by enzyme-linked immunosorbent assay. Liver Transpl. 2011 Jun; 17(6):723-32. PMID: 21618694; PMCID: PMC3293624.
      Citations: 9     Fields:    Translation:Humans
    163. Cazanave SC, Mott JL, Elmi NA, Bronk SF, Masuoka HC, Charlton MR, Gores GJ. A role for miR-296 in the regulation of lipoapoptosis by targeting PUMA. J Lipid Res. 2011 Aug; 52(8):1517-25. PMID: 21633093; PMCID: PMC3137017.
      Citations: 42     Fields:    Translation:HumansAnimalsCells
    164. Bzowej N, Nelson DR, Terrault NA, Everson GT, Teng LL, Prabhakar A, Charlton MR, PHOENIX Study Group. PHOENIX: A randomized controlled trial of peginterferon alfa-2a plus ribavirin as a prophylactic treatment after liver transplantation for hepatitis C virus. Liver Transpl. 2011 May; 17(5):528-38. PMID: 21506241; PMCID: PMC3736350.
      Citations: 40     Fields:    Translation:Humans
    165. Ribeireiro T, Swain J, Sarr M, Kendrick M, Que F, Sanderson S, Krishnan A, Viker K, Watt K, Charlton M. NAFLD and insulin resistance do not increase the risk of postoperative complications among patients undergoing bariatric surgery--a prospective analysis. Obes Surg. 2011 Mar; 21(3):310-5. PMID: 20922498.
      Citations: 9     Fields:    Translation:Humans
    166. Wang X, Esquivel C, Nes E, Shi C, Papanikolaou N, Charlton M. The neutron dose equivalent evaluation and shielding at the maze entrance of a Varian Clinac 23EX treatment room. Med Phys. 2011 Mar; 38(3):1141-9. PMID: 21520826.
      Citations:    Fields:    
    167. Coss E, Watt KD, Pedersen R, Dierkhising R, Heimbach JK, Charlton MR. Predictors of cardiovascular events after liver transplantation: a role for pretransplant serum troponin levels. Liver Transpl. 2011 Jan; 17(1):23-31. PMID: 21254341.
      Citations: 24     Fields:    Translation:HumansCells
    168. Charlton MR, Thompson A, Veldt BJ, Watt K, Tillmann H, Poterucha JJ, Heimbach JK, Goldstein D, McHutchison J. Interleukin-28B polymorphisms are associated with histological recurrence and treatment response following liver transplantation in patients with hepatitis C virus infection. Hepatology. 2011 Jan; 53(1):317-24. PMID: 21254179; PMCID: PMC3835596.
      Citations: 59     Fields:    Translation:Humans
    169. Satapathy SK, Charlton MR. Posttransplant metabolic syndrome: new evidence of an epidemic and recommendations for management. Liver Transpl. 2011 Jan; 17(1):1-6. PMID: 21254337.
      Citations: 8     Fields:    Translation:Humans
    170. Gawrieh S, Baye TM, Carless M, Wallace J, Komorowski R, Kleiner DE, Andris D, Makladi B, Cole R, Charlton M, Curran J, Dyer TD, Charlesworth J, Wilke R, Blangero J, Kissebah AH, Olivier M. Hepatic gene networks in morbidly obese patients with nonalcoholic fatty liver disease. Obes Surg. 2010 Dec; 20(12):1698-709. PMID: 20473581; PMCID: PMC8375563.
      Citations: 22     Fields:    Translation:Humans
    171. Charlton MR. Fibrosing NASH: on being a blind man in a dark room looking for a black cat (that isn't there). Gastroenterology. 2011 Jan; 140(1):25-8. PMID: 21110967.
      Citations: 3     Fields:    Translation:Humans
    172. Liu SS, Schneekloth TD, Talwalkar JA, Kim WR, Poterucha JJ, Charlton MR, Wiesner RH, Gross JB. Impact of depressive symptoms and their treatment on completing antiviral treatment in patients with chronic hepatitis C. J Clin Gastroenterol. 2010 Sep; 44(8):e178-85. PMID: 20495464.
      Citations: 7     Fields:    Translation:HumansCells
    173. Watt KD, Coss E, Pedersen RA, Dierkhising R, Heimbach JK, Charlton MR. Pretransplant serum troponin levels are highly predictive of patient and graft survival following liver transplantation. Liver Transpl. 2010 Aug; 16(8):990-8. PMID: 20677290.
      Citations: 11     Fields:    Translation:Humans
    174. Asrani SK, Kim WR, Pedersen RA, Charlton MR, Kremers WK, Therneau TM, Rosen CB, Dean PG. Daclizumab induction therapy in liver transplant recipients with renal insufficiency. Aliment Pharmacol Ther. 2010 Sep; 32(6):776-86. PMID: 20659283; PMCID: PMC3606263.
      Citations: 3     Fields:    Translation:Humans
    175. Huebert RC, Vasdev MM, Shergill U, Das A, Huang BQ, Charlton MR, LaRusso NF, Shah VH. Aquaporin-1 facilitates angiogenic invasion in the pathological neovasculature that accompanies cirrhosis. Hepatology. 2010 Jul; 52(1):238-48. PMID: 20578142; PMCID: PMC2928054.
      Citations: 26     Fields:    Translation:HumansAnimalsCells
    176. Cao S, Yaqoob U, Das A, Shergill U, Jagavelu K, Huebert RC, Routray C, Abdelmoneim S, Vasdev M, Leof E, Charlton M, Watts RJ, Mukhopadhyay D, Shah VH. Neuropilin-1 promotes cirrhosis of the rodent and human liver by enhancing PDGF/TGF-beta signaling in hepatic stellate cells. J Clin Invest. 2010 Jul; 120(7):2379-94. PMID: 20577048; PMCID: PMC2898590.
      Citations: 81     Fields:    Translation:HumansAnimalsCells
    177. Watt KD, Pedersen RA, Kremers WK, Heimbach JK, Charlton MR. Evolution of causes and risk factors for mortality post-liver transplant: results of the NIDDK long-term follow-up study. Am J Transplant. 2010 Jun; 10(6):1420-7. PMID: 20486907; PMCID: PMC2891375.
      Citations: 200     Fields:    Translation:Humans
    178. Watt KD, Charlton MR. Metabolic syndrome and liver transplantation: a review and guide to management. J Hepatol. 2010 Jul; 53(1):199-206. PMID: 20451282.
      Citations: 51     Fields:    Translation:Humans
    179. Akazawa Y, Cazanave S, Mott JL, Elmi N, Bronk SF, Kohno S, Charlton MR, Gores GJ. Palmitoleate attenuates palmitate-induced Bim and PUMA up-regulation and hepatocyte lipoapoptosis. J Hepatol. 2010 Apr; 52(4):586-93. PMID: 20206402; PMCID: PMC2847010.
      Citations: 119     Fields:    Translation:HumansAnimalsCells
    180. Heimbach JK, Charlton MR. Antibody-based immunosuppression following liver transplantation: the plot thickens. Am J Transplant. 2010 Mar; 10(3):445-6. PMID: 20121726.
      Citations:    Fields:    Translation:HumansCells
    181. Charlton M. Fetal obesity syndrome: maternal nutrition as a cause of nonalcoholic steatohepatitis. Hepatology. 2009 Dec; 50(6):1696-8. PMID: 19937683.
      Citations: 1     Fields:    Translation:HumansAnimals
    182. Charlton M. Obesity, hyperlipidemia, and metabolic syndrome. Liver Transpl. 2009 Nov; 15 Suppl 2:S83-9. PMID: 19877024.
      Citations: 19     Fields:    Translation:Humans
    183. Charlton MR, Wall WJ, Ojo AO, Textor S, Shihab FS, Marotta P, Cantarovich M, Eason JD, Wiesner RH, Ramsay MA, Garcia-Valdecasas JC, Neuberger JM, Feng S, Davis CL, Gonwa TA, International Liver Transplantation Society Expert Panel, Ginès P. Report of the first international liver transplantation society expert panel consensus conference on renal insufficiency in liver transplantation. Liver Transpl. 2009 Nov; 15(11):S1-34. PMID: 19877213.
      Citations: 29     Fields:    Translation:Humans
    184. Charlton M. Medical hurricane: health care reform and hepatology. Hepatology. 2009 Nov; 50(5):1339-40. PMID: 19877299.
      Citations: 1     Fields:    Translation:Humans
    185. Koehler E, Watt K, Charlton M. Fatty liver and liver transplantation. Clin Liver Dis. 2009 Nov; 13(4):621-30. PMID: 19818309.
      Citations: 10     Fields:    Translation:Humans
    186. Cazanave SC, Mott JL, Elmi NA, Bronk SF, Werneburg NW, Akazawa Y, Kahraman A, Garrison SP, Zambetti GP, Charlton MR, Gores GJ. JNK1-dependent PUMA expression contributes to hepatocyte lipoapoptosis. J Biol Chem. 2009 Sep 25; 284(39):26591-602. PMID: 19638343; PMCID: PMC2785347.
      Citations: 107     Fields:    Translation:HumansAnimalsCells
    187. Raichlin E, Daly RC, Rosen CB, McGregor CG, Charlton MR, Frantz RP, Clavell AL, Rodeheffer RJ, Pereira NL, Kremers WK, Kushwaha SS, Edwards BS. Combined heart and liver transplantation: a single-center experience. Transplantation. 2009 Jul 27; 88(2):219-25. PMID: 19623017.
      Citations: 28     Fields:    Translation:Humans
    188. Butt FK, Gritsch HA, Schulam P, Danovitch GM, Wilkinson A, Del Pizzo J, Kapur S, Serur D, Katznelson S, Busque S, Melcher ML, McGuire S, Charlton M, Hil G, Veale JL. Asynchronous, out-of-sequence, transcontinental chain kidney transplantation: a novel concept. Am J Transplant. 2009 Sep; 9(9):2180-5. PMID: 19563335.
      Citations: 8     Fields:    Translation:Humans
    189. Watt K, Veldt B, Charlton M. A practical guide to the management of HCV infection following liver transplantation. Am J Transplant. 2009 Aug; 9(8):1707-13. PMID: 19538491.
      Citations: 25     Fields:    Translation:Humans
    190. Veldt BJ, Poterucha JJ, Watt KD, Wiesner RH, Hay JE, Rosen CB, Heimbach JK, Janssen HL, Charlton MR. Insulin resistance, serum adipokines and risk of fibrosis progression in patients transplanted for hepatitis C. Am J Transplant. 2009 Jun; 9(6):1406-13. PMID: 19459812.
      Citations: 31     Fields:    Translation:Humans
    191. Charlton M, Viker K, Krishnan A, Sanderson S, Veldt B, Kaalsbeek AJ, Kendrick M, Thompson G, Que F, Swain J, Sarr M. Differential expression of lumican and fatty acid binding protein-1: new insights into the histologic spectrum of nonalcoholic fatty liver disease. Hepatology. 2009 Apr; 49(4):1375-84. PMID: 19330863; PMCID: PMC2674237.
      Citations: 67     Fields:    Translation:Humans
    192. Veldt BJ, Poterucha JJ, Watt KD, Wiesner RH, Hay JE, Kremers WK, Rosen CB, Heimbach JK, Charlton MR. Impact of pegylated interferon and ribavirin treatment on graft survival in liver transplant patients with recurrent hepatitis C infection. Am J Transplant. 2008 Nov; 8(11):2426-33. PMID: 18727694.
      Citations: 35     Fields:    Translation:Humans
    193. Charlton M. Cirrhosis and liver failure in nonalcoholic fatty liver disease: Molehill or mountain? Hepatology. 2008 May; 47(5):1431-3. PMID: 18393323; PMCID: PMC2661567.
      Citations: 30     Fields:    Translation:Humans
    194. Leonard J, Heimbach JK, Malinchoc M, Watt K, Charlton M. The impact of obesity on long-term outcomes in liver transplant recipients-results of the NIDDK liver transplant database. Am J Transplant. 2008 Mar; 8(3):667-72. PMID: 18294163.
      Citations: 49     Fields:    Translation:Humans
    195. Charlton M, Angulo P, Chalasani N, Merriman R, Viker K, Charatcharoenwitthaya P, Sanderson S, Gawrieh S, Krishnan A, Lindor K. Low circulating levels of dehydroepiandrosterone in histologically advanced nonalcoholic fatty liver disease. Hepatology. 2008 Feb; 47(2):484-92. PMID: 18220286; PMCID: PMC2906146.
      Citations: 46     Fields:    Translation:Humans
    196. Otley CC, Griffin MD, Charlton MR, Edwards BS, Neuburg M, Stasko T, Reduction of Immunosuppression Task Force of the International Transplant Skin Cancer Collaborative. Reduction of immunosuppression for transplant-associated skin cancer: thresholds and risks. Br J Dermatol. 2007 Dec; 157(6):1183-8. PMID: 17916206.
      Citations: 9     Fields:    Translation:Humans
    197. McCashland T, Watt K, Lyden E, Adams L, Charlton M, Smith AD, McGuire BM, Biggins SW, Neff G, Burton JR, Vargas H, Donovan J, Trotter J, Faust T. Retransplantation for hepatitis C: results of a U.S. multicenter retransplant study. Liver Transpl. 2007 Sep; 13(9):1246-53. PMID: 17763405.
      Citations: 17     Fields:    Translation:Humans
    198. Florman S, Alloway R, Kalayoglu M, Punch J, Bak T, Melancon J, Klintmalm G, Busque S, Charlton M, Lake J, Dhadda S, Wisemandle K, Wirth M, Fitzsimmons W, Holman J, First MR. Once-daily tacrolimus extended release formulation: experience at 2 years postconversion from a Prograf-based regimen in stable liver transplant recipients. Transplantation. 2007 Jun 27; 83(12):1639-42. PMID: 17589349.
      Citations: 10     Fields:    Translation:HumansCTClinical Trials
    199. Krishnan A, Viker K, Rietema H, Telgenkamp M, Knudsen B, Charlton M. Prolonged engraftment of human hepatocytes in mice transgenic for the deleted form of human hepatocyte growth factor. Hepatol Res. 2007 Oct; 37(10):854-62. PMID: 17573952.
      Citations: 8     
    200. Charlton M. Approach to recurrent hepatitis C following liver transplantation. Curr Gastroenterol Rep. 2007 Mar; 9(1):23-30. PMID: 17335674.
      Citations: 2     Fields:    Translation:HumansPHPublic Health
    201. Leerapun A, Suravarapu SV, Bida JP, Clark RJ, Sanders EL, Mettler TA, Stadheim LM, Aderca I, Moser CD, Nagorney DM, LaRusso NF, de Groen PC, Menon KV, Lazaridis KN, Gores GJ, Charlton MR, Roberts RO, Therneau TM, Katzmann JA, Roberts LR. The utility of Lens culinaris agglutinin-reactive alpha-fetoprotein in the diagnosis of hepatocellular carcinoma: evaluation in a United States referral population. Clin Gastroenterol Hepatol. 2007 Mar; 5(3):394-402; quiz 267. PMID: 17368240; PMCID: PMC1931510.
      Citations: 50     Fields:    Translation:Humans
    202. Charlton M. Noninvasive indices of fibrosis in NAFLD: starting to think about a three-hit (at least) phenomenon. Am J Gastroenterol. 2007 Feb; 102(2):409-11. PMID: 17311653.
      Citations: 4     Fields:    Translation:Humans
    203. Schiano TD, Charlton M, Younossi Z, Galun E, Pruett T, Tur-Kaspa R, Eren R, Dagan S, Graham N, Williams PV, Andrews J. Monoclonal antibody HCV-AbXTL68 in patients undergoing liver transplantation for HCV: results of a phase 2 randomized study. Liver Transpl. 2006 Sep; 12(9):1381-9. PMID: 16933235.
      Citations: 41     Fields:    Translation:HumansCellsCTClinical Trials
    204. Charlton MR, Pockros PJ, Harrison SA. Impact of obesity on treatment of chronic hepatitis C. Hepatology. 2006 Jun; 43(6):1177-86. PMID: 16729327.
      Citations: 36     Fields:    Translation:Humans
    205. Charlton M. Hepatocyte tails. Clin Gastroenterol Hepatol. 2006 May; 4(5):564-5. PMID: 16678074.
      Citations:    Fields:    Translation:HumansCells
    206. Charlton M. Branched-chain amino-acid granules: can they improve survival in patients with liver cirrhosis? Nat Clin Pract Gastroenterol Hepatol. 2006 Feb; 3(2):72-3. PMID: 16456570.
      Citations:    Fields:    Translation:Humans
    207. Charlton M. Perioperative viral kinetics: new insights or the Emperor's new clothes? Liver Transpl. 2006 Feb; 12(2):194-5. PMID: 16447194.
      Citations:    Fields:    Translation:HumansCellsPHPublic Health
    208. Charlton M. Branched-chain amino acid enriched supplements as therapy for liver disease. J Nutr. 2006 01; 136(1 Suppl):295S-8S. PMID: 16365102.
      Citations: 50     Fields:    Translation:Humans
    209. Charlton M. Recurrence of hepatitis C infection: Where are we now? Liver Transpl. 2005 Nov; (11 Suppl 2):S57-62. PMID: 16237717.
      Citations: 3     Fields:    Translation:HumansPHPublic Health
    210. Gawrieh S, Papouchado BG, Burgart LJ, Kobayashi S, Charlton MR, Gores GJ. Early hepatic stellate cell activation predicts severe hepatitis C recurrence after liver transplantation. Liver Transpl. 2005 Oct; 11(10):1207-13. PMID: 16184568.
      Citations: 13     Fields:    Translation:Humans
    211. Gallegos-Orozco JF, E Yurk C, Wang N, Rakela J, Charlton MR, Cutting GR, Balan V. Lack of association of common cystic fibrosis transmembrane conductance regulator gene mutations with primary sclerosing cholangitis. Am J Gastroenterol. 2005 Apr; 100(4):874-8. PMID: 15784035.
      Citations: 7     Fields:    Translation:Humans
    212. Charlton M. Retransplantation for HCV--the view through a broken crystal ball. Liver Transpl. 2005 Apr; 11(4):382-3. PMID: 15776456.
      Citations:    Fields:    Translation:Humans
    213. Burak KW, Rosen CB, Fidler JL, Hesley GK, Nagorney D, Charlton MR, Brandhagen DJ. Hypophosphatemia after right hepatectomy for living donor liver transplantation. Can J Gastroenterol. 2004 Dec; 18(12):729-33. PMID: 15605137.
      Citations: 2     Fields:    Translation:Humans
    214. Charlton M. Nonalcoholic fatty liver disease: a review of current understanding and future impact. Clin Gastroenterol Hepatol. 2004 Dec; 2(12):1048-58. PMID: 15625647.
      Citations: 130     Fields:    Translation:Humans
    215. Charlton M, Ruppert K, Belle SH, Bass N, Schafer D, Wiesner RH, Detre K, Wei Y, Everhart J. Long-term results and modeling to predict outcomes in recipients with HCV infection: results of the NIDDK liver transplantation database. Liver Transpl. 2004 Sep; 10(9):1120-30. PMID: 15350002.
      Citations: 17     Fields:    Translation:HumansCells
    216. Charlton M. Obesity in potential living donors: success with simplicity. Liver Transpl. 2004 Jun; 10(6):726-7. PMID: 15162465.
      Citations:    Fields:    Translation:Humans
    217. Charlton M, Wiesner R. Natural history and management of hepatitis C infection after liver transplantation. Semin Liver Dis. 2004; 24 Suppl 2:79-88. PMID: 15346250.
      Citations: 8     Fields:    Translation:HumansCells
    218. Charlton M. Liver biopsy, viral kinetics, and the impact of viremia on severity of hepatitis C virus recurrence. Liver Transpl. 2003 Nov; 9(11):S58-62. PMID: 14586897.
      Citations: 11     Fields:    Translation:HumansCells
    219. Charlton M. Management of recurrence of hepatitis C infection following liver transplantation. Minerva Chir. 2003 Oct; 58(5):717-24. PMID: 14603150.
      Citations: 1     Fields:    Translation:Humans
    220. Charlton M. Natural history of hepatitis C and outcomes following liver transplantation. Clin Liver Dis. 2003 Aug; 7(3):585-602. PMID: 14509528.
      Citations: 5     Fields:    Translation:HumansCells
    221. Guichelaar MM, Benson JT, Malinchoc M, Krom RA, Wiesner RH, Charlton MR. Risk factors for and clinical course of non-anastomotic biliary strictures after liver transplantation. Am J Transplant. 2003 Jul; 3(7):885-90. PMID: 12814481.
      Citations: 73     Fields:    Translation:Humans
    222. Sreekumar R, Rosado B, Rasmussen D, Charlton M. Hepatic gene expression in histologically progressive nonalcoholic steatohepatitis. Hepatology. 2003 Jul; 38(1):244-51. PMID: 12830008.
      Citations: 50     Fields:    Translation:HumansCells
    223. Germer JJ, Charlton MR, Ishitani MB, Forehand CD, Patel R. Characterization of hepatitis B virus surface antigen and polymerase mutations in liver transplant recipients pre- and post-transplant. Am J Transplant. 2003 Jun; 3(6):743-53. PMID: 12780567.
      Citations: 4     Fields:    Translation:Humans
    224. Charlton M. Branched-chain amino acid-enriched supplements as therapy for liver disease: Rasputin lives. Gastroenterology. 2003 Jun; 124(7):1980-2. PMID: 12806634.
      Citations: 1     Fields:    Translation:Humans
    225. Charlton M. The impact of advancing donor age on histologic recurrence of hepatitis C infection: the perils of ignored maternal advice. Liver Transpl. 2003 May; 9(5):535-7. PMID: 12740801.
      Citations:    Fields:    Translation:Humans
    226. Charlton M, Charlton M. Pre-emptive treatment of recurrent hepatitis C infection. Liver Transpl. 2002 Oct; 8(10 Suppl 1):S50-4. PMID: 12362299.
      Citations: 2     Fields:    Translation:HumansPHPublic Health
    227. Razonable RR, Burak KW, van Cruijsen H, Brown RA, Charlton MR, Smith TF, Espy MJ, Kremers W, Wilson JA, Groettum C, Wiesner R, Paya CV, Razonable RR, Burak KW, van Cruijsen H, Brown RA, Charlton MR, Smith TF, Espy MJ, Kremers W, Wilson JA, Groettum C, Wiesner R, Paya CV. The pathogenesis of hepatitis C virus is influenced by cytomegalovirus. Clin Infect Dis. 2002 Oct 15; 35(8):974-81. PMID: 12355385.
      Citations: 20     Fields:    Translation:HumansCells
    228. Sreekumar R, Rasmussen DL, Wiesner RH, Charlton MR, Sreekumar R, Rasmussen DL, Wiesner RH, Charlton MR. Differential allograft gene expression in acute cellular rejection and recurrence of hepatitis C after liver transplantation. Liver Transpl. 2002 Sep; 8(9):814-21. PMID: 12200784.
      Citations: 12     Fields:    Translation:Humans
    229. Narayanan Menon KV, Poterucha JJ, El-Amin OM, Burgart LJ, Kremers WK, Rosen CB, Wiesner RH, Charlton M. Treatment of posttransplantation recurrence of hepatitis C with interferon and ribavirin: lessons on tolerability and efficacy. Liver Transpl. 2002 Jul; 8(7):623-9. PMID: 12089717.
      Citations: 13     Fields:    Translation:Humans
    230. Griffiths TR, Charlton M, Neal DE, Powell PH. Treatment of carcinoma in situ with intravesical bacillus Calmette-Guerin without maintenance. J Urol. 2002 Jun; 167(6):2408-12. PMID: 11992047.
      Citations: 20     Fields:    Translation:Humans
    231. Gunneson TJ, Menon KV, Wiesner RH, Daniels JA, Hay JE, Charlton MR, Brandhagen DJ, Rosen CB, Porayko MK. Ultrasound-assisted percutaneous liver biopsy performed by a physician assistant. Am J Gastroenterol. 2002 Jun; 97(6):1472-5. PMID: 12094868.
      Citations: 15     Fields:    Translation:Humans
    232. Kakar S, Burgart LJ, Charlton MR, Saito Y, Halling K, Thibodeau SN, Kakar S, Burgart LJ, Charlton MR, Saito Y, Halling K, Thibodeau SN. Origin of adenocarcinoma in a transplanted liver determined by microsatellite analysis. Hum Pathol. 2002 Apr; 33(4):435-6. PMID: 12055679.
      Citations: 3     Fields:    Translation:HumansCells
    233. Charlton M. Patient and graft survival following liver transplantation for hepatitis C: much ado about something. Gastroenterology. 2002 Apr; 122(4):1162-5. PMID: 11910367.
      Citations:    Fields:    Translation:Humans
    234. Charlton M, Sreekumar R, Rasmussen D, Lindor K, Nair KS. Apolipoprotein synthesis in nonalcoholic steatohepatitis. Hepatology. 2002 Apr; 35(4):898-904. PMID: 11915037.
      Citations: 82     Fields:    Translation:HumansCells
    235. Crippin JS, McCashland T, Terrault N, Sheiner P, Charlton MR, Crippin JS, McCashland T, Terrault N, Sheiner P, Charlton MR. A pilot study of the tolerability and efficacy of antiviral therapy in hepatitis C virus-infected patients awaiting liver transplantation. Liver Transpl. 2002 Apr; 8(4):350-5. PMID: 11965579.
      Citations: 58     Fields:    Translation:HumansCellsCTClinical Trials
    236. Burak KW, Kremers WK, Batts KP, Wiesner RH, Rosen CB, Razonable RR, Paya CV, Charlton MR, Burak KW, Kremers WK, Batts KP, Wiesner RH, Rosen CB, Razonable RR, Paya CV, Charlton MR. Impact of cytomegalovirus infection, year of transplantation, and donor age on outcomes after liver transplantation for hepatitis C. Liver Transpl. 2002 Apr; 8(4):362-9. PMID: 11965581.
      Citations: 35     Fields:    Translation:HumansCells
    237. Charlton MR. Mycophenolate and hepatitis C: salve on a wound or gasoline on a fire? Liver Transpl. 2002 Jan; 8(1):47-9. PMID: 11799485.
      Citations: 1     Fields:    Translation:HumansPHPublic Health
    238. Boirie Y, Short KR, Ahlman B, Charlton M, Nair KS. Tissue-specific regulation of mitochondrial and cytoplasmic protein synthesis rates by insulin. Diabetes. 2001 Dec; 50(12):2652-8. PMID: 11723046.
      Citations: 37     Fields:    Translation:AnimalsCells
    239. Charlton M. Hepatitis C infection in liver transplantation. Am J Transplant. 2001 Sep; 1(3):197-203. PMID: 12102252.
      Citations: 20     Fields:    Translation:Humans
    240. Charlton M, Kasparova P, Weston S, Lindor K, Maor-Kendler Y, Wiesner RH, Rosen CB, Batts KP. Frequency of nonalcoholic steatohepatitis as a cause of advanced liver disease. Liver Transpl. 2001 Jul; 7(7):608-14. PMID: 11460228.
      Citations: 53     Fields:    Translation:Humans
    241. Ahlman B, Charlton M, Fu A, Berg C, O'Brien P, Nair KS. Insulin's effect on synthesis rates of liver proteins. A swine model comparing various precursors of protein synthesis. Diabetes. 2001 May; 50(5):947-54. PMID: 11334437.
      Citations: 12     Fields:    Translation:AnimalsCells
    242. Czaja AJ, Carpenter HA, Roberts SK, Charlton MR, Porayko MK, Rosen CB, Wiesner RH, González-Koch A. Recurrent autoimmune hepatitis after orthotopic liver transplantation. Liver Transpl. 2001 Apr; 7(4):302-10. PMID: 11303289.
      Citations: 34     Fields:    Translation:Humans
    243. Figueiredo F, Dickson ER, Pasha T, Kasparova P, Therneau T, Malinchoc M, DiCecco S, Francisco-Ziller N, Charlton M. Impact of nutritional status on outcomes after liver transplantation. Transplantation. 2000 Nov 15; 70(9):1347-52. PMID: 11087151.
      Citations: 38     Fields:    Translation:Humans
    244. Sreekumar R, Gonzalez-Koch A, Maor-Kendler Y, Batts K, Moreno-Luna L, Poterucha J, Burgart L, Wiesner R, Kremers W, Rosen C, Charlton MR. Early identification of recipients with progressive histologic recurrence of hepatitis C after liver transplantation. Hepatology. 2000 Nov; 32(5):1125-30. PMID: 11050065.
      Citations: 29     Fields:    Translation:HumansCells
    245. Figueiredo FA, Dickson ER, Pasha TM, Porayko MK, Therneau TM, Malinchoc M, DiCecco SR, Francisco-Ziller NM, Kasparova P, Charlton MR. Utility of standard nutritional parameters in detecting body cell mass depletion in patients with end-stage liver disease. Liver Transpl. 2000 Sep; 6(5):575-81. PMID: 10980056.
      Citations: 35     Fields:    Translation:Humans
    246. Maor-Kendler Y, Batts KP, Burgart LJ, Wiesner RH, Krom RA, Rosen CB, Charlton MR. Comparative allograft histology after liver transplantation for cryptogenic cirrhosis, alcohol, hepatitis C, and cholestatic liver diseases. Transplantation. 2000 Jul 27; 70(2):292-7. PMID: 10933151.
      Citations: 12     Fields:    Translation:Humans
    247. Charlton M. Genotype 1b and severity of posttransplant recurrence of hepatitis C infection- unconvictable felon or wrongly accused? Liver Transpl. 2000 Mar; 6(2):243-5. PMID: 10719029.
      Citations:    Fields:    Translation:HumansCells
    248. Cleavinger PJ, Persing DH, Li H, Moore SB, Charlton MR, Sievers C, Therneau TM, Zein NN. Prevalence of TT virus infection in blood donors with elevated ALT in the absence of known hepatitis markers. Am J Gastroenterol. 2000 Mar; 95(3):772-6. PMID: 10710073.
      Citations: 8     Fields:    Translation:HumansCells
    249. Guerrero RB, Batts KP, Burgart LJ, Barrett SL, Germer JJ, Poterucha JJ, Wiesner RH, Charlton MR, Persing DH. Early detection of hepatitis C allograft reinfection after orthotopic liver transplantation: a molecular and histologic study. Mod Pathol. 2000 Mar; 13(3):229-37. PMID: 10757333.
      Citations: 10     Fields:    Translation:HumansCells
    250. Khadra MH, Pickard RS, Charlton M, Powell PH, Neal DE. A prospective analysis of 1,930 patients with hematuria to evaluate current diagnostic practice. J Urol. 2000 Feb; 163(2):524-7. PMID: 10647670.
      Citations: 71     Fields:    Translation:Humans
    251. Charlton M, Ahlman B, Nair KS. The effect of insulin on human small intestinal mucosal protein synthesis. Gastroenterology. 2000 Feb; 118(2):299-306. PMID: 10648458.
      Citations: 12     Fields:    Translation:HumansCells
    252. Graziadei IW, Wiesner RH, Marotta PJ, Porayko MK, Hay JE, Charlton MR, Poterucha JJ, Rosen CB, Gores GJ, LaRusso NF, Krom RA. Long-term results of patients undergoing liver transplantation for primary sclerosing cholangitis. Hepatology. 1999 Nov; 30(5):1121-7. PMID: 10534330.
      Citations: 78     Fields:    Translation:Humans
    253. Zein NN, Arslan M, Li H, Charlton MR, Gross JB, Poterucha JJ, Therneau TM, Kolbert CP, Persing DH. Clinical significance of TT virus infection in patients with chronic hepatitis C. Am J Gastroenterol. 1999 Oct; 94(10):3020-7. PMID: 10520863.
      Citations: 7     Fields:    Translation:HumansCells
    254. Charlton M, Seaberg E. Impact of immunosuppression and acute rejection on recurrence of hepatitis C: results of the National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database. Liver Transpl Surg. 1999 Jul; 5(4 Suppl 1):S107-14. PMID: 10431024.
      Citations: 29     Fields:    Translation:Humans
    255. Graziadei IW, Wiesner RH, Batts KP, Marotta PJ, LaRusso NF, Porayko MK, Hay JE, Gores GJ, Charlton MR, Ludwig J, Poterucha JJ, Steers JL, Krom RA. Recurrence of primary sclerosing cholangitis following liver transplantation. Hepatology. 1999 Apr; 29(4):1050-6. PMID: 10094945.
      Citations: 64     Fields:    Translation:HumansCTClinical Trials
    256. Everhart JE, Wei Y, Eng H, Charlton MR, Persing DH, Wiesner RH, Germer JJ, Lake JR, Zetterman RK, Hoofnagle JH. Recurrent and new hepatitis C virus infection after liver transplantation. Hepatology. 1999 Apr; 29(4):1220-6. PMID: 10094968.
      Citations: 12     Fields:    Translation:HumansCellsCTClinical Trials
    257. Brandhagen DJ, Gross JB, Poterucha JJ, Charlton MR, Detmer J, Kolberg J, Gossard AA, Batts KP, Kim WR, Germer JJ, Wiesner RH, Persing DH. The clinical significance of simultaneous infection with hepatitis G virus in patients with chronic hepatitis C. Am J Gastroenterol. 1999 Apr; 94(4):1000-5. PMID: 10201473.
      Citations: 3     Fields:    Translation:HumansCells
    258. Charlton MR, Nair KS. Role of hyperglucagonemia in catabolism associated with type 1 diabetes: effects on leucine metabolism and the resting metabolic rate. Diabetes. 1998 Nov; 47(11):1748-56. PMID: 9792544.
      Citations: 19     Fields:    Translation:HumansCells
    259. Charlton M, Seaberg E, Wiesner R, Everhart J, Zetterman R, Lake J, Detre K, Hoofnagle J. Predictors of patient and graft survival following liver transplantation for hepatitis C. Hepatology. 1998 Sep; 28(3):823-30. PMID: 9731579.
      Citations: 89     Fields:    Translation:HumansCells
    260. Charlton M, Adjei P, Poterucha J, Zein N, Moore B, Therneau T, Krom R, Wiesner R. TT-virus infection in North American blood donors, patients with fulminant hepatic failure, and cryptogenic cirrhosis. Hepatology. 1998 Sep; 28(3):839-42. PMID: 9731581.
      Citations: 40     Fields:    Translation:Humans
    261. Charlton M, Nair KS. Protein metabolism in insulin-dependent diabetes mellitus. J Nutr. 1998 02; 128(2 Suppl):323S-327S. PMID: 9478016.
      Citations: 26     Fields:    Translation:Humans
    262. Charlton MR, Brandhagen D, Wiesner RH, Gross JB, Detmer J, Collins M, Kolberg J, Krom RA, Persing DH. Hepatitis G virus infection in patients transplanted for cryptogenic cirrhosis: red flag or red herring? Transplantation. 1998 Jan 15; 65(1):73-6. PMID: 9448147.
      Citations: 1     Fields:    Translation:HumansCells
    263. Charlton MR, Balagopal P, Nair KS. Skeletal muscle myosin heavy chain synthesis in type 1 diabetes. Diabetes. 1997 Aug; 46(8):1336-40. PMID: 9231659.
      Citations: 8     Fields:    Translation:Humans
    264. Charlton MR, Kondo M, Roberts SK, Steers JL, Krom RA, Wiesner RH. Liver transplantation for cryptogenic cirrhosis. Liver Transpl Surg. 1997 Jul; 3(4):359-64. PMID: 9346764.
      Citations: 16     Fields:    Translation:Humans
    265. Charlton MR. Protein metabolism and liver disease. Baillieres Clin Endocrinol Metab. 1996 Oct; 10(4):617-35. PMID: 9022955.
      Citations: 19     Fields:    Translation:Humans
    266. Charlton MR. Branched chains revisited. Gastroenterology. 1996 Jul; 111(1):252-5. PMID: 8698209.
      Citations: 2     Fields:    Translation:Humans
    267. Charlton MR, Adey DB, Nair KS. Evidence for a catabolic role of glucagon during an amino acid load. J Clin Invest. 1996 Jul 01; 98(1):90-9. PMID: 8690809; PMCID: PMC507404.
      Citations: 26     Fields:    Translation:HumansCTClinical Trials
    268. Martin JL, Plevak DJ, Flannery KD, Charlton M, Poterucha JJ, Humphreys CE, Derfus G, Pohl LR. Hepatotoxicity after desflurane anesthesia. Anesthesiology. 1995 Nov; 83(5):1125-9. PMID: 7486167.
      Citations: 8     Fields:    Translation:Humans
    269. Craft AW, Parker L, Openshaw S, Charlton M, Newell J, Birch JM, Blair V. Cancer in young people in the north of England, 1968-85: analysis by census wards. J Epidemiol Community Health. 1993 Apr; 47(2):109-15. PMID: 8326267; PMCID: PMC1059737.
      Citations: 6     Fields:    Translation:Humans
    270. Croker JR, Williams SG, Charlton M, Vaira D, Dowsett J. Endoscopic therapy for bile duct stones in a geriatric population. Postgrad Med J. 1992 Jun; 68(800):457-60. PMID: 1437928; PMCID: PMC2399356.
      Citations: 1     Fields:    Translation:Humans
    271. Griffin S, Desai J, Charlton M, Townsend E, Fountain SW. Factors influencing mortality and morbidity following oesophageal resection. Eur J Cardiothorac Surg. 1989; 3(5):419-23; discussion 424. PMID: 2635923.
      Citations: 3     Fields:    Translation:Humans
    Charlton's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (760)
    Explore
    _
    Co-Authors (29)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _
    Physical Neighbors
    _